data_2jxd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jxd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CB ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 37' ' ' TYR . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.804 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.804 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 42' ' ' THR . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.445 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.515 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.44 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 10.0 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.578 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 37' ' ' TYR . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.415 ' CG ' ' HZ2' ' A' ' 55' ' ' LYS . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.1 m-80 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 40' ' ' GLU . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.488 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 42' ' ' THR . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.458 HG21 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.453 HG23 ' CD2' ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.451 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.569 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.355 64.8 pttt . . . . . 0 CA--C 1.507 -0.674 0 CA-C-O 122.581 1.181 . . . . 0.0 113.951 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' NH1' HD13 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 37' ' ' TYR . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.537 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.446 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.811 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.811 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.621 ' HB2' ' SG ' ' A' ' 14' ' ' CYS 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.518 HG21 ' N ' ' A' ' 55' ' ' LYS . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.239 0.541 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 37' ' ' TYR . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.532 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.599 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 37' ' ' TYR . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 HD23 ' CE1' ' A' ' 37' ' ' TYR 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.504 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.547 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.54 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.851 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 16.3 m-80 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.41 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.851 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 40' ' ' GLU 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.494 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.547 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.526 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.56 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 48' ' ' ARG 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 42' ' ' THR . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 23' ' ' PRO . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 37' ' ' TYR . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 34' ' ' MET . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.525 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.636 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.698 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.636 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 62' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.546 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.528 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.479 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.57 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.582 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.523 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.703 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.703 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 42' ' ' THR . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 5.9 m120 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 N--CA 1.425 -1.723 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.536 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.616 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 45' ' ' MET . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.481 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 46' ' ' LYS . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 2.5 t-20 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.475 ' NH1' HD13 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 37' ' ' TYR . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.417 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' TYR . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HB3' ' HZ2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' NH1' ' A' ' 10' ' ' ARG . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.506 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.508 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 37' ' ' TYR . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.626 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.574 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.559 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.48 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.528 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.578 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH1' HD12 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.601 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 37' ' ' TYR . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 47' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' GLU 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.472 ' HA ' HD11 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.848 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.848 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.476 ' HA ' HG23 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 CA--C 1.503 -1.044 0 N-CA-C 108.486 -1.39 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.75 102.65 5.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 70.58 -47.56 0.64 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.895 1.678 . . . . 0.0 113.434 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.74 -171.84 19.62 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.08 -0.62 3.04 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.123 0.487 . . . . 0.0 110.519 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -86.78 -15.75 38.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.064 0.459 . . . . 0.0 110.475 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.42 98.83 11.93 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? 77.26 -67.01 0.22 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.971 1.308 . . . . 0.0 109.32 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.404 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.561 ' CB ' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 37' ' ' TYR . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.804 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.804 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.484 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.648 ' HB2' ' O ' ' A' ' 42' ' ' THR . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.445 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -162.94 177.97 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -158.52 141.23 14.49 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 56.54 3.2 Favored Glycine 0 C--N 1.313 -0.744 0 CA-C-O 121.128 0.293 . . . . 0.0 113.336 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.04 -9.35 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.322 0.582 . . . . 0.0 109.904 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -85.94 -19.62 30.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.706 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -169.11 164.2 11.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -86.14 134.31 33.81 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.515 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.44 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 10.0 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.578 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 37' ' ' TYR . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.414 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.415 ' CG ' ' HZ2' ' A' ' 55' ' ' LYS . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' ASP . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.479 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.447 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.1 m-80 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.635 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.532 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 40' ' ' GLU . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.468 HG21 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 7' ' ' SER . 4.1 Cg_exo . . . . . 0 N--CA 1.439 -1.678 0 N-CA-C 108.368 -1.435 . . . . 0.0 108.368 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -64.72 123.33 19.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.4 t80 71.8 -41.3 0.5 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.248 1.419 . . . . 0.0 111.666 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.17 81.77 0.57 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -81.44 -11.52 59.21 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.269 0.628 . . . . 0.0 110.376 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.76 -37.17 81.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.415 ' O ' ' HD2' ' A' ' 1' ' ' PRO . 20.2 m -92.04 89.82 7.12 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.96 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? 51.32 29.71 5.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.521 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.447 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.488 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 42' ' ' THR . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.458 HG21 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.453 HG23 ' CD2' ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.451 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.599 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.569 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.438 -1.773 0 N-CA-C 108.789 -1.274 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -96.97 -61.44 1.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.52 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -155.55 155.14 32.85 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.031 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 8' ' ' LYS . . . 136.22 167.19 11.15 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -108.85 141.01 41.52 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.793 0.796 . . . . 0.0 112.09 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 72.91 -61.55 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 111.874 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 p -87.31 -60.96 1.83 Allowed 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 4' ' ' GLY 0.355 64.8 pttt 56.2 127.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 127.296 2.239 . . . . 0.0 113.951 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' NH1' HD13 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 37' ' ' TYR . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.537 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.446 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.554 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.811 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.811 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.621 ' HB2' ' SG ' ' A' ' 14' ' ' CYS 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.518 HG21 ' N ' ' A' ' 55' ' ' LYS . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 N--CA 1.443 -1.474 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -84.58 121.26 27.37 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -142.03 -36.94 0.41 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.92 77.55 1.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.49 137.14 40.22 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 74.7 152.46 0.13 Allowed 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.644 1.215 . . . . 0.0 113.116 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 t 61.18 -84.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 113.589 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.93 -10.84 58.6 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 37' ' ' TYR . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.547 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.532 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.599 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 37' ' ' TYR . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 HD23 ' CE1' ' A' ' 37' ' ' TYR 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.504 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 HG21 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.45 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.547 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.44 -1.624 0 N-CA-C 108.84 -1.254 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.484 4.5 pp0? 59.18 -70.28 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 t80 59.76 39.12 21.21 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.612 1.196 . . . . 0.0 109.36 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.32 155.08 7.83 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -100.07 131.56 45.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.879 0.847 . . . . 0.0 112.416 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -103.04 -37.42 7.78 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.949 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 9' ' ' TYR . 18.7 m -99.56 -174.22 2.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -64.13 -32.68 74.34 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' SER . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.483 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.54 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.497 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.851 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' HB3' HD21 ' A' ' 19' ' ' LEU . 16.3 m-80 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.41 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.851 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 40' ' ' GLU 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' GLU . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.494 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.547 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.526 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.439 -1.677 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -159.61 146.25 16.42 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 59.32 37.73 23.36 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.812 0.695 . . . . 0.0 110.957 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.73 -137.3 2.99 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.7 pt? -109.39 -8.47 15.05 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.384 0.592 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 67.58 101.08 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.615 1.166 . . . . 0.0 111.99 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 p -67.99 -61.95 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.931 0.396 . . . . 0.0 109.998 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -132.6 26.99 4.39 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.56 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.55 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.595 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.575 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 48' ' ' ARG 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 42' ' ' THR . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.658 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.446 -1.267 0 N-CA-C 108.068 -1.551 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.89 -75.51 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 53.8 34.8 19.99 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.133 0.973 . . . . 0.0 112.124 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.15 79.25 0.64 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.482 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.21 142.25 34.84 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.157 0.583 . . . . 0.0 111.475 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.26 -74.27 0.61 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -134.69 13.83 3.7 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.56 -176.8 3.3 Favored 'General case' 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 23' ' ' PRO . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.492 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 37' ' ' TYR . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 34' ' ' MET . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.525 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.636 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.698 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.636 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.49 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.467 ' CB ' ' HA ' ' A' ' 62' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.546 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.347 -1.828 . . . . 0.0 107.347 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 65.86 106.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.145 1.528 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 65.78 -172.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.4 46.6 2.25 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.628 1.104 . . . . 0.0 112.801 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -94.02 115.43 27.76 Favored 'General case' 0 N--CA 1.401 -2.904 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -89.08 -22.19 23.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.12 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -77.36 164.89 25.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.18 168.32 14.32 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.528 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' HD11 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.479 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.57 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.582 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.464 ' HA ' HG23 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.49 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.515 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.596 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.596 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.447 -1.262 0 N-CA-C 109.127 -1.144 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 7.0 tt0 -91.0 162.92 14.51 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -116.35 -5.29 11.79 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.774 0.797 . . . . 0.0 110.521 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' H ' ' HG2' ' A' ' 2' ' ' GLN . . . -90.66 -70.18 1.21 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.546 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 10.9 mp -97.99 140.57 32.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -110.02 146.09 35.91 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.694 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t 69.0 18.47 8.4 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.622 1.169 . . . . 0.0 110.323 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -149.0 138.51 21.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.587 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.523 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.703 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.703 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.759 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.759 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.516 ' HA ' HG21 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 42' ' ' THR . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HG21 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.526 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 5.9 m120 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 N--CA 1.437 -1.842 0 N-CA-C 107.757 -1.67 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.44 136.32 2.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.585 0.553 . . . . 0.0 111.741 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -159.06 132.12 7.09 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.29 1.436 . . . . 0.0 108.989 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.66 60.49 0.61 Allowed Glycine 0 C--N 1.291 -1.951 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 tp -87.77 -29.82 20.74 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.345 0.593 . . . . 0.0 110.261 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.21 174.73 5.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -84.37 56.1 3.65 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.817 1.294 . . . . 0.0 110.221 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -152.77 147.08 25.65 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.536 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.616 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 45' ' ' MET . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.481 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 46' ' ' LYS . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 2.5 t-20 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.781 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.532 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 8.5 Cg_exo . . . . . 0 N--CA 1.449 -1.133 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -84.89 174.39 9.85 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.819 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 71.52 28.2 2.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.228 1.411 . . . . 0.0 108.944 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.61 -161.4 17.04 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.09 108.6 21.28 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 1' ' ' PRO . 29.6 p90 -109.07 112.67 24.98 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.496 0.665 . . . . 0.0 110.714 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 -12.36 59.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.632 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -145.57 153.55 41.2 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.475 ' NH1' HD13 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.556 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 37' ' ' TYR . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.417 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.44 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' TYR . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.484 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.475 HD13 ' NH1' ' A' ' 10' ' ' ARG . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.054 -1.172 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -70.92 123.84 22.95 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 123.379 0.424 . . . . 0.0 110.427 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -130.66 -50.8 1.06 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.96 43.49 0.57 Allowed Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.206 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 6' ' ' PHE . 2.4 pt? -94.75 -62.34 1.34 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.111 0.482 . . . . 0.0 110.255 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.507 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 62.7 m-85 -143.12 -46.46 0.3 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 102.248 -3.242 . . . . 0.0 102.248 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 m -75.15 97.52 3.5 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 162.85 31.41 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.508 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.496 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 37' ' ' TYR . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' HB3' ' HH ' ' A' ' 37' ' ' TYR . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.626 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.574 ' O ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.559 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.48 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.468 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.535 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.528 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.578 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 109.945 -0.829 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -61.64 113.1 2.52 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.285 0.634 . . . . 0.0 110.992 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.7 t80 65.05 28.29 12.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.634 1.174 . . . . 0.0 110.181 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.96 55.25 4.9 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.094 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -91.56 -10.07 41.93 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.098 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 60.5 91.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.033 1.333 . . . . 0.0 113.895 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -163.15 -53.96 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.12 166.26 30.33 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH1' HD12 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.601 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.601 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 37' ' ' TYR . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.531 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.568 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 47' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.561 ' HB2' ' HA ' ' A' ' 40' ' ' GLU 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.487 HG21 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.472 ' HA ' HD11 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 N--CA 1.443 -1.454 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.73 160.73 31.73 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 123.941 0.776 . . . . 0.0 109.855 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.3 t80 68.69 70.29 0.29 Allowed 'General case' 0 C--O 1.254 1.303 0 CA-C-O 122.65 1.214 . . . . 0.0 109.523 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 -79.62 1.81 Allowed Glycine 0 N--CA 1.425 -2.075 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.317 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 pp 170.28 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.51 1.524 . . . . 0.0 109.2 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -84.66 6.57 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.3 t -87.61 157.32 19.15 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -77.72 168.83 19.33 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.523 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.848 ' ND2' ' HG1' ' A' ' 42' ' ' THR . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.848 ' HG1' ' ND2' ' A' ' 39' ' ' ASN . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.524 ' CD2' HG22 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.476 ' HA ' HG23 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.524 HG22 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.45 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.993 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.661 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.993 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.658 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.76 ' HA ' HG22 ' A' ' 47' ' ' ILE . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.76 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.658 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.428 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 15.1 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.799 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.2 m120 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.636 HD21 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.688 ' HA ' HG22 ' A' ' 47' ' ' ILE . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.688 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.489 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.816 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.65 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.683 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG3' ' HG2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.61 HG21 HD22 ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.355 64.8 pttt . . . . . 0 CA--C 1.507 -0.674 0 CA-C-O 122.581 1.181 . . . . 0.0 113.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NH1' HD11 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HG3' HG11 ' A' ' 29' ' ' VAL . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 20' ' ' PRO . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 19' ' ' LEU . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.885 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' HB2' ' A' ' 38' ' ' ALA . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.66 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.825 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.981 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.507 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.239 0.541 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.557 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.522 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.896 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.761 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.737 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.737 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.483 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.72 ' HA ' HD12 ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HD3' ' H ' ' A' ' 56' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 43' ' ' LEU . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' HD21 ' A' ' 19' ' ' LEU . 15.0 m120 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.867 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.584 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 43' ' ' LEU . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.67 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HG2' HD11 ' A' ' 54' ' ' ILE . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.67 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 61' ' ' PRO . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.884 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 38' ' ' ALA . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.444 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.884 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 17' ' ' TYR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.712 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.72 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.54 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HA ' HD12 ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.644 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HD13 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 40' ' ' GLU . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 38' ' ' ALA . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.881 HD22 HG21 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.725 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.881 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.665 ' HA ' HD12 ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HG2' HD13 ' A' ' 43' ' ' LEU . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.51 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 43' ' ' LEU . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.712 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.496 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.712 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.771 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.8 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 16' ' ' GLN . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.517 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 56' ' ' ILE . 20.4 m-20 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 29' ' ' VAL . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 N--CA 1.425 -1.723 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.514 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.468 ' H ' ' CD1' ' A' ' 54' ' ' ILE . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 66.5 t30 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.825 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' NH1' HD11 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 43' ' ' LEU . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.595 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 29' ' ' VAL 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.801 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.801 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.656 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.565 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' OH ' ' HB1' ' A' ' 38' ' ' ALA . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.521 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.852 HG22 ' HB2' ' A' ' 38' ' ' ALA . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.58 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.412 HD22 ' CB ' ' A' ' 42' ' ' THR . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.747 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' NH1' HD11 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.545 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' A' ' 23' ' ' PRO . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 54' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CE2' HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG3' HD13 ' A' ' 43' ' ' LEU . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.879 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 23' ' ' PRO . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.812 HD22 HG21 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.753 ' HA ' HG22 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.557 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' GLY . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 9' ' ' TYR . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 CA--C 1.503 -1.044 0 N-CA-C 108.486 -1.39 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.75 102.65 5.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 70.58 -47.56 0.64 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.895 1.678 . . . . 0.0 113.434 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.74 -171.84 19.62 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.08 -0.62 3.04 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.123 0.487 . . . . 0.0 110.519 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -86.78 -15.75 38.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.064 0.459 . . . . 0.0 110.475 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.42 98.83 11.93 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? 77.26 -67.01 0.22 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.971 1.308 . . . . 0.0 109.32 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.45 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.993 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.661 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.993 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.658 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.76 ' HA ' HG22 ' A' ' 47' ' ' ILE . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.76 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.658 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.428 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -162.94 177.97 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -158.52 141.23 14.49 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 56.54 3.2 Favored Glycine 0 C--N 1.313 -0.744 0 CA-C-O 121.128 0.293 . . . . 0.0 113.336 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.04 -9.35 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.322 0.582 . . . . 0.0 109.904 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -85.94 -19.62 30.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.706 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -169.11 164.2 11.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 134.31 33.81 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 15.1 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.799 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.2 m120 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.636 HD21 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.688 ' HA ' HG22 ' A' ' 47' ' ' ILE . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.688 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 7' ' ' SER . 4.1 Cg_exo . . . . . 0 N--CA 1.439 -1.678 0 N-CA-C 108.368 -1.435 . . . . 0.0 108.368 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -64.72 123.33 19.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.4 t80 71.8 -41.3 0.5 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.248 1.419 . . . . 0.0 111.666 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.17 81.77 0.57 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.7 pt? -81.44 -11.52 59.21 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.269 0.628 . . . . 0.0 110.376 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.76 -37.17 81.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HD2' ' A' ' 1' ' ' PRO . 20.2 m -92.04 89.82 7.12 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.96 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? 51.32 29.71 5.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.489 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.816 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.65 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.683 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG3' ' HG2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.61 HG21 HD22 ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.438 -1.773 0 N-CA-C 108.789 -1.274 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -96.97 -61.44 1.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.52 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -155.55 155.14 32.85 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.031 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 8' ' ' LYS . . . 136.22 167.19 11.15 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -108.85 141.01 41.52 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.793 0.796 . . . . 0.0 112.09 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 72.91 -61.55 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 111.874 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 p -87.31 -60.96 1.83 Allowed 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 4' ' ' GLY 0.355 64.8 pttt 56.2 127.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 127.296 2.239 . . . . 0.0 113.951 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NH1' HD11 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HG3' HG11 ' A' ' 29' ' ' VAL . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 20' ' ' PRO . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 19' ' ' LEU . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.885 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' HB2' ' A' ' 38' ' ' ALA . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.66 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.825 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.981 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 N--CA 1.443 -1.474 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -84.58 121.26 27.37 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -142.03 -36.94 0.41 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.92 77.55 1.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.49 137.14 40.22 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 74.7 152.46 0.13 Allowed 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.644 1.215 . . . . 0.0 113.116 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 t 61.18 -84.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 113.589 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.93 -10.84 58.6 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.557 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.522 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.896 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.761 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.737 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.737 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.483 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.72 ' HA ' HD12 ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.44 -1.624 0 N-CA-C 108.84 -1.254 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.484 4.5 pp0? 59.18 -70.28 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 t80 59.76 39.12 21.21 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.612 1.196 . . . . 0.0 109.36 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.32 155.08 7.83 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -100.07 131.56 45.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.879 0.847 . . . . 0.0 112.416 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -103.04 -37.42 7.78 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.949 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' TYR . 18.7 m -99.56 -174.22 2.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -64.13 -32.68 74.34 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' SER . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HD3' ' H ' ' A' ' 56' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 43' ' ' LEU . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' HD21 ' A' ' 19' ' ' LEU . 15.0 m120 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.867 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.439 -1.677 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -159.61 146.25 16.42 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 59.32 37.73 23.36 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.812 0.695 . . . . 0.0 110.957 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.73 -137.3 2.99 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.7 pt? -109.39 -8.47 15.05 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.384 0.592 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 67.58 101.08 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.615 1.166 . . . . 0.0 111.99 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 p -67.99 -61.95 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.931 0.396 . . . . 0.0 109.998 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -132.6 26.99 4.39 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.584 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 43' ' ' LEU . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.67 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HG2' HD11 ' A' ' 54' ' ' ILE . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.67 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 61' ' ' PRO . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.446 -1.267 0 N-CA-C 108.068 -1.551 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.89 -75.51 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 53.8 34.8 19.99 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.133 0.973 . . . . 0.0 112.124 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.15 79.25 0.64 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.482 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.21 142.25 34.84 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.157 0.583 . . . . 0.0 111.475 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.26 -74.27 0.61 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -134.69 13.83 3.7 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.56 -176.8 3.3 Favored 'General case' 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.884 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 38' ' ' ALA . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.444 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.884 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 17' ' ' TYR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.712 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.72 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.54 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HA ' HD12 ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.347 -1.828 . . . . 0.0 107.347 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 65.86 106.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.145 1.528 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 65.78 -172.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.4 46.6 2.25 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.628 1.104 . . . . 0.0 112.801 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -94.02 115.43 27.76 Favored 'General case' 0 N--CA 1.401 -2.904 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -89.08 -22.19 23.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.12 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -77.36 164.89 25.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.18 168.32 14.32 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.644 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.535 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HD13 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 40' ' ' GLU . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 38' ' ' ALA . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.881 HD22 HG21 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.725 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.881 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.665 ' HA ' HD12 ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.447 -1.262 0 N-CA-C 109.127 -1.144 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 7.0 tt0 -91.0 162.92 14.51 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -116.35 -5.29 11.79 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.774 0.797 . . . . 0.0 110.521 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.51 ' H ' ' HG2' ' A' ' 2' ' ' GLN . . . -90.66 -70.18 1.21 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 10.9 mp -97.99 140.57 32.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -110.02 146.09 35.91 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.694 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t 69.0 18.47 8.4 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.622 1.169 . . . . 0.0 110.323 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -149.0 138.51 21.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HG2' HD13 ' A' ' 43' ' ' LEU . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.51 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 43' ' ' LEU . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.712 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.496 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.712 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.771 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.8 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 16' ' ' GLN . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.517 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 56' ' ' ILE . 20.4 m-20 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 29' ' ' VAL . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 N--CA 1.437 -1.842 0 N-CA-C 107.757 -1.67 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -167.44 136.32 2.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.585 0.553 . . . . 0.0 111.741 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -159.06 132.12 7.09 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.29 1.436 . . . . 0.0 108.989 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.66 60.49 0.61 Allowed Glycine 0 C--N 1.291 -1.951 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 tp -87.77 -29.82 20.74 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.345 0.593 . . . . 0.0 110.261 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.21 174.73 5.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -84.37 56.1 3.65 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.817 1.294 . . . . 0.0 110.221 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -152.77 147.08 25.65 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.514 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.468 ' H ' ' CD1' ' A' ' 54' ' ' ILE . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 66.5 t30 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.825 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 8.5 Cg_exo . . . . . 0 N--CA 1.449 -1.133 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -84.89 174.39 9.85 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.819 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 71.52 28.2 2.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.228 1.411 . . . . 0.0 108.944 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.61 -161.4 17.04 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.09 108.6 21.28 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 1' ' ' PRO . 29.6 p90 -109.07 112.67 24.98 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.496 0.665 . . . . 0.0 110.714 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 -12.36 59.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.632 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -145.57 153.55 41.2 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' NH1' HD11 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 43' ' ' LEU . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.595 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 29' ' ' VAL 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.801 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.801 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.656 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.565 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.054 -1.172 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -70.92 123.84 22.95 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 123.379 0.424 . . . . 0.0 110.427 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -130.66 -50.8 1.06 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.96 43.49 0.57 Allowed Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.206 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -94.75 -62.34 1.34 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.111 0.482 . . . . 0.0 110.255 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 62.7 m-85 -143.12 -46.46 0.3 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 102.248 -3.242 . . . . 0.0 102.248 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HA ' HG21 ' A' ' 11' ' ' THR . 8.4 m -75.15 97.52 3.5 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 162.85 31.41 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 7' ' ' SER . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' OH ' ' HB1' ' A' ' 38' ' ' ALA . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.521 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.852 HG22 ' HB2' ' A' ' 38' ' ' ALA . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.58 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.412 HD22 ' CB ' ' A' ' 42' ' ' THR . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.747 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 109.945 -0.829 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -61.64 113.1 2.52 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.285 0.634 . . . . 0.0 110.992 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.7 t80 65.05 28.29 12.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.634 1.174 . . . . 0.0 110.181 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.96 55.25 4.9 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.094 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -91.56 -10.07 41.93 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.098 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 60.5 91.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.033 1.333 . . . . 0.0 113.895 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -163.15 -53.96 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.12 166.26 30.33 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' NH1' HD11 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.545 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' A' ' 23' ' ' PRO . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 54' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 N--CA 1.443 -1.454 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 7' ' ' SER . 65.4 tt0 -72.73 160.73 31.73 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 123.941 0.776 . . . . 0.0 109.855 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.3 t80 68.69 70.29 0.29 Allowed 'General case' 0 C--O 1.254 1.303 0 CA-C-O 122.65 1.214 . . . . 0.0 109.523 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 -79.62 1.81 Allowed Glycine 0 N--CA 1.425 -2.075 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.317 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 6' ' ' PHE . 2.8 pp 170.28 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.51 1.524 . . . . 0.0 109.2 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.4 ' N ' HD12 ' A' ' 5' ' ' LEU . 48.2 p90 -84.66 6.57 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 2' ' ' GLN . 34.3 t -87.61 157.32 19.15 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -77.72 168.83 19.33 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CE2' HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG3' HD13 ' A' ' 43' ' ' LEU . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.879 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 23' ' ' PRO . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.812 HD22 HG21 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.753 ' HA ' HG22 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.557 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' GLY . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 9' ' ' TYR . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.45 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.993 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.661 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.993 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.658 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.76 ' HA ' HG22 ' A' ' 47' ' ' ILE . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.76 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.658 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.428 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 10.0 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.799 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.1 m-80 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.636 HD21 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.688 ' HA ' HG22 ' A' ' 47' ' ' ILE . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.688 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.489 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.816 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.65 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.683 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG3' ' HG2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.1 OUTLIER -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.61 HG21 HD22 ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.355 64.8 pttt . . . . . 0 CA--C 1.507 -0.674 0 CA-C-O 122.581 1.181 . . . . 0.0 113.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NH1' HD11 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HG3' HG11 ' A' ' 29' ' ' VAL . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 20' ' ' PRO . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 19' ' ' LEU . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.885 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' HB2' ' A' ' 38' ' ' ALA . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.66 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.825 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.825 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.981 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.507 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.239 0.541 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.557 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.522 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.896 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.761 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.737 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.737 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.483 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.72 ' HA ' HD12 ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HD3' ' H ' ' A' ' 56' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 43' ' ' LEU . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' HD21 ' A' ' 19' ' ' LEU . 16.3 m-80 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.867 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.804 0.335 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.584 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 43' ' ' LEU . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.67 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HG2' HD11 ' A' ' 54' ' ' ILE . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.67 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 61' ' ' PRO . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.884 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 38' ' ' ALA . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.444 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.521 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.884 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 17' ' ' TYR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.712 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.72 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.54 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HA ' HD12 ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.644 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.535 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HD13 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 40' ' ' GLU . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 38' ' ' ALA . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.881 HD22 HG21 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.725 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.881 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.665 ' HA ' HD12 ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HG2' HD13 ' A' ' 43' ' ' LEU . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.51 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 43' ' ' LEU . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.712 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.496 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.712 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.771 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.8 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 16' ' ' GLN . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.517 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.9 m120 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 29' ' ' VAL . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt . . . . . 0 N--CA 1.425 -1.723 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.514 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.468 ' H ' ' CD1' ' A' ' 54' ' ' ILE . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 2.5 t-20 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.825 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' NH1' HD11 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 43' ' ' LEU . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.524 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.595 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 29' ' ' VAL 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.801 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.801 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.656 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.565 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' OH ' ' HB1' ' A' ' 38' ' ' ALA . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.521 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.852 HG22 ' HB2' ' A' ' 38' ' ' ALA . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.58 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 HD22 ' CB ' ' A' ' 42' ' ' THR . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.747 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.747 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' NH1' HD11 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.545 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' A' ' 23' ' ' PRO . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 54' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CE2' HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG3' HD13 ' A' ' 43' ' ' LEU . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.879 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 23' ' ' PRO . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.812 HD22 HG21 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.753 ' HA ' HG22 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.557 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' GLY . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 9' ' ' TYR . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 CA--C 1.503 -1.044 0 N-CA-C 108.486 -1.39 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -75.75 102.65 5.51 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 t80 70.58 -47.56 0.64 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.895 1.678 . . . . 0.0 113.434 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.74 -171.84 19.62 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -134.08 -0.62 3.04 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.123 0.487 . . . . 0.0 110.519 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -86.78 -15.75 38.38 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.064 0.459 . . . . 0.0 110.475 -176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.42 98.83 11.93 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 10.2 mmpt? 77.26 -67.01 0.22 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.971 1.308 . . . . 0.0 109.32 -176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 55' ' ' LYS . 0.2 OUTLIER 173.63 -161.33 0.02 OUTLIER 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.45 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -105.93 108.56 20.14 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.078 179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -79.34 134.03 59.33 Favored Pre-proline 0 C--N 1.26 -3.306 0 CA-C-N 114.578 -1.192 . . . . 0.0 112.532 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 73.9 Cg_endo -72.91 151.55 50.87 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.905 2.404 . . . . 0.0 112.067 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.68 85.39 2.43 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.781 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -87.04 83.33 7.5 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.0 m -120.27 29.43 7.49 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -154.33 -166.13 2.27 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 70.38 33.41 2.52 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 123.248 1.499 . . . . 0.0 108.727 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -89.21 68.76 8.18 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-N 112.463 -2.153 . . . . 0.0 110.725 -171.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.26 161.84 21.68 Favored Pre-proline 0 N--CA 1.423 -1.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.164 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.21 -13.19 30.85 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.304 2.003 . . . . 0.0 110.043 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.93 -135.44 2.35 Favored Glycine 0 N--CA 1.415 -2.73 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -149.98 112.14 3.33 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' ARG . 11.5 Cg_endo -96.19 158.13 1.35 Allowed 'Trans proline' 0 N--CA 1.437 -1.829 0 C-N-CA 122.442 2.095 . . . . 0.0 110.988 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 3.5 mpt_? 63.89 175.54 0.17 Allowed 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 125.41 1.484 . . . . 0.0 111.938 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -139.54 121.37 15.47 Favored 'General case' 0 C--N 1.265 -3.082 0 CA-C-N 113.01 -1.905 . . . . 0.0 108.973 169.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.44 138.69 8.8 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 89.9 m-20 -133.88 79.94 56.36 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.325 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.993 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.2 Cg_exo -58.16 -44.5 38.54 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 124.759 3.639 . . . . 0.0 117.638 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.5 m -103.82 168.75 2.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-O 122.362 1.077 . . . . 0.0 113.049 -167.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -117.25 136.22 53.24 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.827 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.79 135.57 12.51 Favored Glycine 0 C--N 1.261 -3.627 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 23.6 p -69.04 -28.63 66.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 16.58 1.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.391 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.0 ttt 62.55 65.48 0.84 Allowed 'General case' 0 C--O 1.244 0.77 0 CA-C-O 122.098 0.951 . . . . 0.0 111.225 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.9 m -160.65 111.3 1.81 Allowed 'General case' 0 C--O 1.201 -1.496 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 m -78.9 118.18 20.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.661 ' HB2' ' HB ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -151.02 -172.3 4.17 Favored 'General case' 0 C--O 1.186 -2.243 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.993 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.47 92.94 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 126.845 2.058 . . . . 0.0 110.65 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.2 p30 174.04 -178.11 0.09 Allowed 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.076 0.95 . . . . 0.0 109.899 174.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.595 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 39.4 tp10 -66.17 -18.5 65.39 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 124.176 0.99 . . . . 0.0 112.88 -176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 87.1 m -115.58 -15.67 11.4 Favored 'General case' 0 CA--C 1.473 -2.003 0 O-C-N 121.494 -0.753 . . . . 0.0 110.211 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.664 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 40.2 p -93.09 -64.09 1.14 Allowed 'General case' 0 N--CA 1.383 -3.819 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.869 172.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.658 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.307 83.5 mt -89.34 -51.34 5.61 Favored 'General case' 2 C--O 1.085 -7.581 0 C-N-CA 115.117 -2.633 . . . . 0.0 111.33 -178.589 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.76 ' HA ' HG22 ' A' ' 47' ' ' ILE . 7.2 m -65.4 -24.68 67.28 Favored 'General case' 0 C--N 1.246 -3.906 0 C-N-CA 118.651 -1.22 . . . . 0.0 113.146 -168.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 15.8 tpt -67.63 -54.44 19.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 168.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.669 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 19.8 tptt -59.34 -41.76 89.94 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.451 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.76 HG22 ' HA ' ' A' ' 44' ' ' CYS . 5.3 tt -74.21 -33.74 35.65 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.38 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -165.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' HG3' ' OE2' ' A' ' 49' ' ' GLU . 6.9 ptp180 -74.38 -38.67 63.1 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.222 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE2' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -179.38 20.97 0.0 OUTLIER 'General case' 0 C--N 1.357 0.923 0 O-C-N 123.914 0.758 . . . . 0.0 111.22 168.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -74.74 -24.11 73.2 Favored Glycine 0 N--CA 1.428 -1.866 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -138.76 -66.28 0.04 OUTLIER Glycine 0 N--CA 1.415 -2.752 0 C-N-CA 118.23 -1.938 . . . . 0.0 112.845 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -156.67 -172.4 4.04 Favored 'General case' 0 CA--C 1.467 -2.224 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 -168.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 91.45 8.07 Favored 'General case' 0 C--N 1.271 -2.82 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 163.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.658 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -51.88 132.4 13.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -117.14 118.52 32.57 Favored 'General case' 0 N--CA 1.402 -2.841 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 167.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.7 pt -73.97 142.96 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 C-N-CA 118.432 -1.307 . . . . 0.0 108.425 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -78.9 -36.04 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-O 122.89 1.329 . . . . 0.0 108.923 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.428 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -131.34 129.69 41.73 Favored 'General case' 1 N--CA 1.362 -4.871 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.186 176.306 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.652 ' HA ' HD12 ' A' ' 56' ' ' ILE . 29.3 p-10 -78.54 1.58 22.01 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.41 -167.8 19.74 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.23 140.07 11.48 Favored 'Trans proline' 0 C--O 1.255 1.343 0 C-N-CA 124.582 3.522 . . . . 0.0 116.473 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.253 1.258 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 174.444 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -162.94 177.97 8.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -158.52 141.23 14.49 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.16 56.54 3.2 Favored Glycine 0 C--N 1.313 -0.744 0 CA-C-O 121.128 0.293 . . . . 0.0 113.336 -176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -103.04 -9.35 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.322 0.582 . . . . 0.0 109.904 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -85.94 -19.62 30.19 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.706 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.3 t -169.11 164.2 11.19 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 134.31 33.81 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.96 -155.74 0.12 Allowed 'General case' 0 C--O 1.245 0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' NH2' ' HB2' ' A' ' 59' ' ' ASN . 70.0 ttp85 -125.87 132.13 52.24 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-O 122.047 0.927 . . . . 0.0 111.839 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -111.62 146.47 34.75 Favored Pre-proline 0 C--N 1.264 -3.142 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.267 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.25 166.94 26.79 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.075 1.85 . . . . 0.0 110.78 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.63 106.43 18.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 15' ' ' SER . 52.1 t -92.31 167.58 11.91 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 122.755 0.422 . . . . 0.0 111.819 -174.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.402 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 19.3 m 76.79 15.73 1.96 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 125.665 1.586 . . . . 0.0 112.247 173.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 10.0 pt20 -130.6 22.78 5.07 Favored 'General case' 0 CA--C 1.496 -1.122 0 CA-C-O 122.366 1.079 . . . . 0.0 111.35 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -110.89 -52.56 2.78 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.012 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.457 ' NH1' ' HA ' ' A' ' 16' ' ' GLN . 0.5 OUTLIER 81.59 148.92 0.09 Allowed 'General case' 0 CA--C 1.509 -0.634 0 C-N-CA 124.594 1.158 . . . . 0.0 111.996 176.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -166.13 155.84 10.78 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.63 -22.05 73.56 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 123.008 2.472 . . . . 0.0 112.773 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.15 -55.89 0.1 Allowed Glycine 0 CA--C 1.488 -1.615 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.8 m -143.54 157.47 59.02 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 124.109 0.964 . . . . 0.0 109.288 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HG3' ' CB ' ' A' ' 39' ' ' ASN . 64.1 Cg_endo -73.97 161.09 41.95 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 C-N-CA 123.771 2.981 . . . . 0.0 112.803 -175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -69.08 -76.14 0.1 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.538 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -166.76 120.92 1.06 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.577 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -174.1 161.36 3.59 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 124.265 1.026 . . . . 0.0 110.617 175.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -157.02 80.4 3.48 Favored Pre-proline 0 CA--C 1.558 1.259 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.799 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 21.9 Cg_exo -68.15 -56.73 0.18 Allowed 'Trans proline' 0 C--O 1.211 -0.871 0 C-N-CA 124.128 3.219 . . . . 0.0 117.834 174.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.683 HG22 ' HB2' ' A' ' 38' ' ' ALA . 34.1 m -103.01 166.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -161.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 32.7 m -113.84 135.33 54.09 Favored 'General case' 0 N--CA 1.397 -3.092 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.914 -168.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.48 109.79 3.08 Favored Glycine 0 C--N 1.271 -3.078 0 N-CA-C 118.92 2.328 . . . . 0.0 118.92 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 29.7 m -82.15 -33.79 29.4 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -81.93 -23.65 36.05 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.793 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.5 tpt -176.53 -61.0 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.2 m -136.2 158.36 44.61 Favored 'General case' 0 C--O 1.156 -3.83 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.162 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 m -73.31 120.53 19.05 Favored 'General case' 0 C--N 1.257 -3.427 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 171.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.9 -169.24 3.28 Favored 'General case' 0 C--O 1.191 -2.014 0 C-N-CA 125.385 1.474 . . . . 0.0 111.709 -171.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.799 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.56 -36.57 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.527 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 161.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 41' ' ' CYS . 4.1 m-80 -54.67 163.64 0.9 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 116.275 1.954 . . . . 0.0 116.275 -165.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 47.3 mt-10 -79.22 21.01 0.48 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.969 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 39' ' ' ASN . 84.3 m -146.13 5.2 0.97 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.334 1.854 . . . . 0.0 107.167 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 m -122.53 -68.26 0.9 Allowed 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.636 HD21 ' CE1' ' A' ' 37' ' ' TYR 0.297 44.9 mt -75.54 -42.95 51.13 Favored 'General case' 2 C--O 1.106 -6.461 0 C-N-CA 113.793 -3.163 . . . . 0.0 109.121 174.569 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.688 ' HA ' HG22 ' A' ' 47' ' ' ILE . 29.3 m -61.13 -23.39 65.5 Favored 'General case' 0 C--N 1.251 -3.693 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -172.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.461 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 95.9 mmm -76.53 -41.47 46.65 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . 6.2 mptp? -62.22 -46.02 90.74 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.444 172.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.688 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.3 tt -73.11 -36.16 49.73 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.203 0 CA-C-O 121.885 0.85 . . . . 0.0 110.801 -168.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.9 ttt-85 -87.4 -39.86 14.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.33 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.59 13.98 2.96 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -175.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.88 -40.14 7.76 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.12 22.68 5.81 Favored Glycine 0 CA--C 1.48 -2.109 0 C-N-CA 119.126 -1.511 . . . . 0.0 113.502 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -142.11 143.97 33.3 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.65 85.67 7.1 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 117.695 -1.602 . . . . 0.0 107.239 169.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 46' ' ' LYS . 1.2 mp -48.88 130.42 6.09 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 CA-C-N 114.188 -1.369 . . . . 0.0 112.255 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.657 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.12 140.31 44.33 Favored 'General case' 1 N--CA 1.375 -4.216 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.458 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.6 pt -92.36 140.87 15.45 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.162 -176.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -78.87 -29.99 14.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 122.236 1.017 . . . . 0.0 109.419 -176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.552 ' HB2' ' SG ' ' A' ' 30' ' ' CYS 0.336 25.2 mmm180 -140.99 147.28 38.48 Favored 'General case' 0 C--N 1.259 -3.331 0 CA-C-N 112.899 -1.955 . . . . 0.0 111.381 174.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.717 ' HA ' HD12 ' A' ' 56' ' ' ILE . 27.8 p-10 -92.82 9.59 34.57 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 113.724 -1.58 . . . . 0.0 112.749 -167.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 156.73 -77.21 0.2 Allowed Glycine 0 C--N 1.293 -1.821 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.32 105.15 2.03 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 C-N-CA 121.421 1.414 . . . . 0.0 109.699 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.9 m . . . . . 0 C--O 1.25 1.089 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 176.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 7' ' ' SER . 4.1 Cg_exo . . . . . 0 N--CA 1.439 -1.678 0 N-CA-C 108.368 -1.435 . . . . 0.0 108.368 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -64.72 123.33 19.06 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.4 t80 71.8 -41.3 0.5 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.248 1.419 . . . . 0.0 111.666 -176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.17 81.77 0.57 Allowed Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 176.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.7 pt? -81.44 -11.52 59.21 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 123.269 0.628 . . . . 0.0 110.376 -178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -67.76 -37.17 81.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HD2' ' A' ' 1' ' ' PRO . 20.2 m -92.04 89.82 7.12 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.96 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? 51.32 29.71 5.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER 63.14 -161.62 0.29 Allowed 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.84 1.256 . . . . 0.0 111.774 176.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.489 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -109.69 114.5 28.15 Favored 'General case' 0 N--CA 1.393 -3.278 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.1 t -89.09 132.29 38.34 Favored Pre-proline 0 C--N 1.264 -3.139 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.911 -176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.08 133.52 25.17 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.483 2.122 . . . . 0.0 112.54 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -84.51 115.65 22.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.35 -17.85 63.74 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.39 0.676 . . . . 0.0 111.059 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 m -53.24 -55.26 25.85 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.297 0.639 . . . . 0.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -91.58 93.38 8.92 Favored 'General case' 0 CA--C 1.485 -1.546 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.87 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -171.93 122.54 0.49 Allowed 'General case' 0 CA--C 1.49 -1.364 0 C-N-CA 128.917 2.887 . . . . 0.0 106.37 167.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -88.73 150.06 23.16 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.875 -0.73 . . . . 0.0 111.926 -173.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp 82.73 101.55 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.84 0 C-N-CA 126.069 1.748 . . . . 0.0 110.431 -169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.95 6.96 5.35 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.739 2.292 . . . . 0.0 109.47 176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.3 -139.71 8.55 Favored Glycine 1 N--CA 1.384 -4.829 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.573 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 86.7 m -108.2 163.2 17.48 Favored Pre-proline 0 C--N 1.268 -2.972 0 CA-C-O 118.948 -0.549 . . . . 0.0 109.564 -172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 29.7 Cg_endo -54.39 149.88 36.14 Favored 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 122.728 2.285 . . . . 0.0 115.109 -175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.255 39.3 ttt180 -113.28 9.13 18.28 Favored 'General case' 0 C--N 1.26 -3.29 0 CA-C-N 111.333 -2.667 . . . . 0.0 107.415 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.259 69.2 m-70 82.98 71.67 0.02 OUTLIER 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.979 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -154.78 136.92 14.75 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -141.3 80.48 16.56 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 76.7 Cg_exo -50.92 -48.78 19.35 Favored 'Trans proline' 0 C--O 1.207 -1.025 0 C-N-CA 124.448 3.432 . . . . 0.0 116.366 176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 38' ' ' ALA . 35.2 m -105.67 164.73 4.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -168.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.8 m -110.11 124.3 51.28 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.103 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.51 116.72 9.64 Favored Glycine 0 C--N 1.267 -3.302 0 CA-C-N 114.429 -1.26 . . . . 0.0 115.841 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.53 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 28.6 t -77.01 -34.27 57.42 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.13 25.18 1.39 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.993 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.2 ttt 65.02 74.26 0.4 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.014 1.326 . . . . 0.0 112.787 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 60.1 m 179.76 102.19 0.03 OUTLIER 'General case' 0 C--O 1.163 -3.489 0 C-N-CA 126.194 1.798 . . . . 0.0 110.323 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.8 m -73.36 116.68 14.2 Favored 'General case' 0 C--N 1.286 -2.17 0 O-C-N 120.809 -1.182 . . . . 0.0 108.528 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.16 -172.6 4.28 Favored 'General case' 0 C--O 1.202 -1.42 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -167.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.816 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.73 87.63 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 126.976 2.11 . . . . 0.0 110.411 162.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -153.48 167.61 28.89 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 3.1 tm-20 -73.56 -22.89 59.94 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 88.9 m -100.48 -12.38 19.38 Favored 'General case' 0 CA--C 1.48 -1.721 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.008 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.65 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 6.4 m -105.82 -60.89 1.57 Allowed 'General case' 0 N--CA 1.394 -3.255 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.818 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' ILE 0.287 84.0 mt -85.4 -47.96 9.47 Favored 'General case' 2 C--O 1.09 -7.309 0 C-N-CA 115.059 -2.656 . . . . 0.0 110.959 179.426 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.346 13.1 m -67.17 -19.7 65.62 Favored 'General case' 1 C--N 1.243 -4.037 0 C-N-CA 117.636 -1.626 . . . . 0.0 114.328 -167.739 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.0 mmt -70.12 -58.29 3.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 164.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.683 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.7 tptt -48.39 -51.35 26.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.634 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.7 tt -73.38 -35.03 45.0 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 O-C-N 123.903 0.752 . . . . 0.0 110.59 -167.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' HG2' ' HG3' ' A' ' 49' ' ' GLU . 36.0 ttt-85 -72.62 -41.45 65.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.276 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' HG3' ' HG2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -179.31 34.87 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.02 -15.91 78.48 Favored Glycine 0 CA--C 1.497 -1.054 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.49 15.0 2.06 Favored Glycine 0 N--CA 1.414 -2.77 0 CA-C-N 114.049 -1.076 . . . . 0.0 111.926 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -152.38 147.19 26.0 Favored 'General case' 0 CA--C 1.451 -2.84 0 C-N-CA 119.009 -1.076 . . . . 0.0 108.721 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.1 OUTLIER -89.49 97.32 11.13 Favored 'General case' 0 C--N 1.259 -3.329 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 171.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.61 HG21 HD22 ' A' ' 43' ' ' LEU 0.303 1.6 mp -59.21 124.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 122.978 1.371 . . . . 0.0 114.25 -177.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 15.0 pttp -127.22 144.18 51.09 Favored 'General case' 1 N--CA 1.369 -4.491 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 172.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -111.33 149.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.457 0 C-N-CA 118.699 -1.2 . . . . 0.0 109.819 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.0 tt -81.4 -41.45 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 CA-C-O 122.809 1.29 . . . . 0.0 107.879 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.646 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.368 20.6 mmm180 -128.24 136.34 50.91 Favored 'General case' 0 N--CA 1.383 -3.811 0 CA-C-N 113.32 -1.764 . . . . 0.0 112.164 173.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 91.8 m-20 -79.87 -6.46 57.45 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 112.367 -2.197 . . . . 0.0 112.718 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.61 -151.38 6.26 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.91 121.58 10.25 Favored 'Trans proline' 0 C--O 1.242 0.719 0 C-N-CA 123.25 2.633 . . . . 0.0 112.909 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 56.9 m . . . . . 0 C--O 1.248 0.999 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.438 -1.773 0 N-CA-C 108.789 -1.274 . . . . 0.0 108.789 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -96.97 -61.44 1.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.52 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -155.55 155.14 32.85 Favored 'General case' 0 C--O 1.254 1.305 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.031 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 8' ' ' LYS . . . 136.22 167.19 11.15 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 mp -108.85 141.01 41.52 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 117.793 0.796 . . . . 0.0 112.09 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 72.91 -61.55 0.5 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 111.874 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 p -87.31 -60.96 1.83 Allowed 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 4' ' ' GLY 0.355 64.8 pttt 56.2 127.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 127.296 2.239 . . . . 0.0 113.951 -176.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.507 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -132.18 -149.18 0.37 Allowed 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -173.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' NH1' HD11 ' A' ' 56' ' ' ILE . 5.6 ptm180 -146.28 150.12 35.17 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 118.326 0.512 . . . . 0.0 109.977 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 54' ' ' ILE . 9.4 t -124.98 145.25 49.57 Favored Pre-proline 0 C--N 1.273 -2.758 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HG3' HG11 ' A' ' 29' ' ' VAL . 13.1 Cg_endo -75.85 157.04 39.34 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.599 1.532 . . . . 0.0 109.4 171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -102.41 95.67 6.42 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.594 ' SG ' ' HB2' ' A' ' 43' ' ' LEU . 1.8 p -79.59 31.14 0.24 Allowed 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 124.841 1.257 . . . . 0.0 113.236 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 14.1 m -110.03 32.47 5.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.096 0.951 . . . . 0.0 108.458 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -122.65 29.45 6.87 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.609 -174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -100.38 126.82 46.79 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.651 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -83.03 6.62 18.25 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -177.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 20' ' ' PRO . 25.7 tp -114.52 144.07 31.12 Favored Pre-proline 0 N--CA 1.4 -2.961 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 19' ' ' LEU . 9.6 Cg_endo -56.23 -26.81 63.08 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.477 2.118 . . . . 0.0 112.334 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.2 -120.2 4.3 Favored Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 72.5 m -144.24 122.23 6.78 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -87.35 130.94 2.93 Favored 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.066 1.844 . . . . 0.0 110.437 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 70.97 143.5 0.06 Allowed 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 125.579 1.552 . . . . 0.0 113.538 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.25 105.36 15.36 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.519 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.15 154.76 45.11 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.906 -179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -127.32 80.24 72.0 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.885 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 48.7 Cg_exo -60.5 -45.38 22.19 Favored 'Trans proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.577 2.852 . . . . 0.0 116.26 176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG22 ' HB2' ' A' ' 38' ' ' ALA . 19.2 m -103.97 171.01 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.94 0.876 . . . . 0.0 113.099 -166.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.37 129.67 56.66 Favored 'General case' 0 N--CA 1.408 -2.563 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.422 -169.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.1 113.14 5.59 Favored Glycine 0 C--N 1.268 -3.245 0 N-CA-C 116.216 1.246 . . . . 0.0 116.216 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 29.5 t -81.92 -24.25 35.75 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.63 23.83 9.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.713 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.9 tmm? 62.74 87.64 0.1 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 125.465 1.506 . . . . 0.0 111.007 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 61.2 m 172.75 110.32 0.01 OUTLIER 'General case' 0 C--O 1.164 -3.405 0 C-N-CA 127.152 2.181 . . . . 0.0 110.495 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.8 m -74.31 116.3 14.81 Favored 'General case' 0 C--N 1.258 -3.377 0 O-C-N 120.923 -1.11 . . . . 0.0 109.413 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.24 -171.07 3.8 Favored 'General case' 0 C--O 1.194 -1.847 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -170.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.885 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.08 98.44 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 127.645 2.378 . . . . 0.0 110.219 164.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.2 p30 168.43 173.83 0.04 OUTLIER 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 125.138 1.375 . . . . 0.0 109.066 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 9.1 tp10 -63.37 -22.41 66.86 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.762 0.825 . . . . 0.0 110.378 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -104.34 -19.99 13.9 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.832 -169.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.66 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 36.9 p -97.36 -63.52 1.12 Allowed 'General case' 0 N--CA 1.391 -3.41 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.765 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.981 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 77.8 mt -78.85 -55.52 5.09 Favored 'General case' 2 C--O 1.111 -6.221 0 C-N-CA 114.565 -2.854 . . . . 0.0 111.228 -176.481 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.825 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.315 89.3 m -56.21 -24.35 41.49 Favored 'General case' 0 C--N 1.271 -2.836 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -170.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 26.4 mmt -70.24 -57.09 5.28 Favored 'General case' 0 C--O 1.258 1.525 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 169.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' THR . 32.6 mmmt -53.63 -44.51 69.6 Favored 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 114.37 -1.286 . . . . 0.0 111.252 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.825 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.5 tt -73.68 -33.05 37.29 Favored 'Isoleucine or valine' 1 N--CA 1.362 -4.841 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.868 -164.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -66.49 -38.95 88.39 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 169.7 22.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 124.882 1.364 . . . . 0.0 110.17 169.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.61 -24.24 76.53 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 108.065 -2.014 . . . . 0.0 108.065 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.54 -70.49 0.08 OUTLIER Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 117.884 -2.103 . . . . 0.0 111.84 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -156.46 -172.99 4.29 Favored 'General case' 0 C--N 1.274 -2.699 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -170.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -83.32 90.64 7.17 Favored 'General case' 0 C--N 1.27 -2.864 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 167.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.981 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -51.59 138.7 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 -177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.48 146.25 50.94 Favored 'General case' 0 N--CA 1.38 -3.964 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 165.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' A' ' 59' ' ' ASN . 39.2 pt -93.01 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.696 0 C-N-CA 118.953 -1.099 . . . . 0.0 108.399 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.2 tt -99.52 -21.0 5.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-O 122.248 1.023 . . . . 0.0 110.198 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 133.01 18.94 Favored 'General case' 0 N--CA 1.382 -3.827 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.654 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.624 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.1 p30 -73.96 4.28 5.63 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.246 1.019 . . . . 0.0 111.686 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.64 -177.04 28.48 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.74 150.17 78.64 Favored 'Trans proline' 0 C--O 1.257 1.437 0 C-N-CA 123.229 2.619 . . . . 0.0 113.534 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.6 m . . . . . 0 C--N 1.3 -1.579 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.305 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo . . . . . 0 N--CA 1.443 -1.474 0 N-CA-C 108.112 -1.534 . . . . 0.0 108.112 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -84.58 121.26 27.37 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -142.03 -36.94 0.41 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.92 77.55 1.48 Allowed Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.17 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.49 137.14 40.22 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 74.7 152.46 0.13 Allowed 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.644 1.215 . . . . 0.0 113.116 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 t 61.18 -84.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.767 1.627 . . . . 0.0 113.589 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -82.93 -10.84 58.6 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER 64.38 -157.22 0.3 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 4.1 ppt_? -128.03 142.08 51.33 Favored 'General case' 0 N--CA 1.393 -3.303 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -101.63 147.37 33.75 Favored Pre-proline 0 C--N 1.252 -3.65 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.0 Cg_endo -81.57 115.53 2.83 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 123.117 2.545 . . . . 0.0 109.892 172.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.15 124.36 30.43 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.6 p -80.37 17.81 1.01 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.1 m -74.71 -18.58 60.49 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -102.02 21.7 14.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 122.4 1.095 . . . . 0.0 110.173 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -110.78 110.66 21.39 Favored 'General case' 0 C--N 1.257 -3.439 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.293 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.3 76.0 1.57 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.923 0.868 . . . . 0.0 109.06 176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' A' ' 21' ' ' GLY . 3.5 mm? -100.63 174.22 3.12 Favored Pre-proline 0 N--CA 1.415 -2.189 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.014 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 19' ' ' LEU . 73.4 Cg_endo -79.25 10.01 3.16 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 121.66 1.573 . . . . 0.0 109.432 167.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 19' ' ' LEU . . . 118.48 -77.14 0.3 Allowed Glycine 0 N--CA 1.407 -3.268 0 N-CA-C 108.816 -1.714 . . . . 0.0 108.816 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.7 m -97.22 171.32 6.13 Favored Pre-proline 0 C--N 1.28 -2.437 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -91.41 157.44 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 C-N-CA 121.243 1.295 . . . . 0.0 112.044 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -67.02 -62.68 1.31 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -171.36 92.05 0.15 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.716 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -172.19 147.64 2.06 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 123.208 0.603 . . . . 0.0 110.153 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 54.8 m-80 -145.86 80.33 10.56 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.788 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 80.8 Cg_exo -50.12 -46.08 30.13 Favored 'Trans proline' 0 N--CA 1.487 1.139 1 C-N-CA 125.527 4.151 . . . . 0.0 117.872 176.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.896 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.7 m -104.34 165.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -167.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 92.2 m -107.79 126.92 53.22 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.142 -171.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -64.23 116.77 9.51 Favored Glycine 0 C--N 1.263 -3.519 0 CA-C-N 114.568 -1.196 . . . . 0.0 115.967 175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.557 ' OG ' ' HG2' ' A' ' 55' ' ' LYS . 95.4 p -73.14 -35.65 66.54 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 170.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -82.71 36.32 0.49 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-N 113.249 -1.796 . . . . 0.0 111.177 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.9 mmt 68.53 15.74 9.13 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 169.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.522 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 28.1 m -133.02 115.81 15.62 Favored 'General case' 0 C--O 1.162 -3.526 0 O-C-N 121.44 -0.787 . . . . 0.0 112.147 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.9 m -73.46 121.52 20.67 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.1 -172.41 4.2 Favored 'General case' 0 C--O 1.194 -1.858 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -168.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.896 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 155.49 105.85 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 C-N-CA 126.464 1.906 . . . . 0.0 110.161 165.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 p30 166.73 -174.24 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 124.97 1.308 . . . . 0.0 109.176 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 44.7 mt-10 -88.11 -6.72 57.75 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -175.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 45' ' ' MET . 80.0 m -108.96 -29.53 8.54 Favored 'General case' 0 CA--C 1.468 -2.187 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.627 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 2.5 m -87.93 -62.18 1.55 Allowed 'General case' 1 N--CA 1.369 -4.485 0 C-N-CA 118.361 -1.336 . . . . 0.0 109.657 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.761 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.291 94.1 mt -85.45 -60.6 1.98 Allowed 'General case' 1 C--O 1.09 -7.334 0 C-N-CA 113.096 -3.442 . . . . 0.0 112.205 178.055 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.737 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.273 11.0 t -54.94 -29.5 56.67 Favored 'General case' 0 N--CA 1.508 2.431 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -169.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' A' ' 41' ' ' CYS . 15.6 tpt -65.43 -58.13 6.61 Favored 'General case' 0 C--O 1.254 1.324 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 42' ' ' THR . 13.3 mptt -53.68 -45.49 70.34 Favored 'General case' 0 C--O 1.211 -0.947 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.177 174.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.737 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.8 -35.07 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.617 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.441 -164.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -66.01 -38.67 89.06 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.6 -0.84 . . . . 0.0 109.389 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 169.19 25.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 124.857 1.348 . . . . 0.0 110.451 167.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.16 -28.56 66.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.235 -1.946 . . . . 0.0 108.235 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.82 -70.57 0.2 Allowed Glycine 0 N--CA 1.42 -2.414 0 C-N-CA 118.214 -1.946 . . . . 0.0 111.133 172.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -154.03 -171.94 4.05 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 -174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.63 85.92 7.2 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 164.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.2 mp -49.67 132.04 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.557 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.56 132.11 56.21 Favored 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 170.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.0 pt -84.57 139.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.408 0 C-N-CA 117.542 -1.663 . . . . 0.0 107.568 178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 9.9 tt -75.51 -37.4 37.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 122.915 1.341 . . . . 0.0 108.319 -178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.483 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.359 45.8 mmm-85 -127.46 136.34 51.66 Favored 'General case' 1 N--CA 1.362 -4.839 0 CA-C-N 112.662 -2.063 . . . . 0.0 112.159 173.819 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.72 ' HA ' HD12 ' A' ' 56' ' ' ILE . 26.5 p-10 -78.3 -2.92 40.39 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 112.473 -2.149 . . . . 0.0 111.925 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.14 -163.3 20.75 Favored Glycine 0 N--CA 1.409 -3.119 0 N-CA-C 106.329 -2.708 . . . . 0.0 106.329 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -47.23 125.7 10.73 Favored 'Trans proline' 0 C--O 1.244 0.777 0 C-N-CA 123.416 2.744 . . . . 0.0 112.198 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.25 1.082 0 O-C-N 124.225 0.953 . . . . 0.0 108.512 179.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo . . . . . 0 N--CA 1.44 -1.624 0 N-CA-C 108.84 -1.254 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.484 4.5 pp0? 59.18 -70.28 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 t80 59.76 39.12 21.21 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 122.612 1.196 . . . . 0.0 109.36 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 132.32 155.08 7.83 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -100.07 131.56 45.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.879 0.847 . . . . 0.0 112.416 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -103.04 -37.42 7.78 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.092 -1.413 . . . . 0.0 108.949 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' TYR . 18.7 m -99.56 -174.22 2.67 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -64.13 -32.68 74.34 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.158 0.98 . . . . 0.0 108.508 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 7' ' ' SER . 0.6 OUTLIER -131.39 -156.26 0.74 Allowed 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 178.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -118.18 120.68 38.45 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 174.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -90.21 154.59 46.98 Favored Pre-proline 0 C--N 1.247 -3.868 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.62 -173.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.501 ' HD3' ' H ' ' A' ' 56' ' ' ILE . 28.7 Cg_endo -60.51 149.34 87.18 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.251 2.634 . . . . 0.0 112.068 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.0 102.04 13.3 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.6 t -79.49 73.77 6.15 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.374 1.083 . . . . 0.0 108.766 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 m -145.25 23.96 1.46 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -139.04 172.96 12.07 Favored 'General case' 0 N--CA 1.394 -3.259 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 77.08 91.42 0.07 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 125.276 1.431 . . . . 0.0 110.784 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.74 92.94 7.23 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 39' ' ' ASN . 11.0 mp -86.93 160.17 50.15 Favored Pre-proline 0 C--N 1.291 -1.967 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.272 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.03 -6.14 15.64 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.602 2.201 . . . . 0.0 110.348 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 159.88 -76.95 0.18 Allowed Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HB3' ' CD ' ' A' ' 23' ' ' PRO . 10.9 m -122.71 174.49 3.34 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 123.437 0.695 . . . . 0.0 111.437 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 22' ' ' CYS . 39.0 Cg_exo -65.43 160.1 44.4 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.592 2.861 . . . . 0.0 118.094 -168.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -125.35 -159.15 0.88 Allowed 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 111.523 -2.58 . . . . 0.0 104.771 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.25 27.5 p80 -93.28 87.22 5.56 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.945 -178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -167.5 127.81 1.44 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.057 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -133.26 80.64 58.15 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 60' ' ' GLY . 87.3 Cg_exo -45.12 -48.16 11.5 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.244 3.296 . . . . 0.0 116.415 175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 43' ' ' LEU . 16.8 m -105.68 168.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -166.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.571 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 62.5 m -116.03 132.56 56.62 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.178 -169.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -72.27 113.82 4.66 Favored Glycine 0 C--N 1.264 -3.417 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 25.1 t -81.2 -24.99 37.1 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -98.27 32.5 2.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.263 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 49.3 ttm 60.35 77.56 0.32 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 125.357 1.463 . . . . 0.0 112.97 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 68.9 m 177.29 103.81 0.02 OUTLIER 'General case' 0 C--O 1.17 -3.105 0 C-N-CA 126.169 1.788 . . . . 0.0 110.218 -178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.3 m -73.54 117.96 15.92 Favored 'General case' 0 C--N 1.271 -2.841 0 O-C-N 120.808 -1.183 . . . . 0.0 108.141 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.74 -170.57 3.69 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -164.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 176.53 -156.21 0.02 OUTLIER 'General case' 0 C--O 1.19 -2.077 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 167.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' HB3' HD21 ' A' ' 19' ' ' LEU . 16.3 m-80 81.6 153.1 0.11 Allowed 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 172.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HA ' ' SG ' ' A' ' 44' ' ' CYS . 37.7 mt-10 -78.24 -11.14 59.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.072 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 51.1 t -117.31 -8.97 11.02 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.654 -172.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.867 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 19.7 m -108.41 -60.86 1.67 Allowed 'General case' 0 N--CA 1.399 -2.994 0 CA-C-O 118.015 -0.993 . . . . 0.0 108.431 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.845 HD22 HG21 ' A' ' 54' ' ' ILE 0.291 60.4 mt -78.2 -45.34 23.3 Favored 'General case' 2 C--O 1.111 -6.185 0 C-N-CA 115.082 -2.647 . . . . 0.0 112.048 179.515 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.272 29.8 m -65.76 -24.94 67.06 Favored 'General case' 0 C--N 1.247 -3.852 0 C-N-CA 118.288 -1.365 . . . . 0.0 113.462 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 26.4 mmt -74.71 -45.88 41.29 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.651 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -55.37 -45.19 76.56 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 113.708 -1.587 . . . . 0.0 112.075 174.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.4 tt -73.28 -32.44 37.75 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.722 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.365 -167.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.0 tpt85 -64.01 -40.3 96.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.068 179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 170.11 22.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.257 1.023 . . . . 0.0 110.185 170.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.44 -25.8 73.4 Favored Glycine 0 N--CA 1.433 -1.539 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.61 -76.99 0.14 Allowed Glycine 0 N--CA 1.402 -3.593 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.115 168.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -155.11 -175.95 5.69 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 -166.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.98 87.06 4.81 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 163.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.845 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -42.49 127.89 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 CA-C-N 114.186 -1.37 . . . . 0.0 114.12 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HD2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -115.35 119.52 36.55 Favored 'General case' 1 N--CA 1.377 -4.088 0 N-CA-C 101.037 -3.69 . . . . 0.0 101.037 165.977 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' ASN . 7.1 pt -70.67 133.44 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.968 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 12.7 tt -70.0 -41.6 79.37 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 CA-C-O 123.118 1.437 . . . . 0.0 108.664 -176.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.573 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.255 16.6 mmm180 -123.49 139.79 53.66 Favored 'General case' 2 N--CA 1.358 -5.035 0 CA-C-N 112.418 -2.174 . . . . 0.0 109.35 175.547 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.672 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.8 p-10 -88.06 12.03 14.54 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.164 -1.834 . . . . 0.0 111.493 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 151.75 -68.28 0.32 Allowed Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -175.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.6 104.08 0.35 Allowed 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 123.109 2.54 . . . . 0.0 114.839 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 55.9 m . . . . . 0 C--O 1.254 1.304 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo . . . . . 0 N--CA 1.439 -1.677 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -159.61 146.25 16.42 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 59.32 37.73 23.36 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.812 0.695 . . . . 0.0 110.957 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -146.73 -137.3 2.99 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.7 pt? -109.39 -8.47 15.05 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 117.384 0.592 . . . . 0.0 110.098 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 67.58 101.08 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.615 1.166 . . . . 0.0 111.99 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 p -67.99 -61.95 1.63 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.931 0.396 . . . . 0.0 109.998 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -132.6 26.99 4.39 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER 56.87 -144.53 0.65 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.516 1.127 . . . . 0.0 110.268 -179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.584 ' HB3' ' NH1' ' A' ' 10' ' ' ARG . 16.8 mtp-105 -109.47 129.43 55.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 9.2 t -125.05 130.5 24.17 Favored Pre-proline 0 C--N 1.249 -3.801 0 C-N-CA 118.988 -1.085 . . . . 0.0 112.109 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HG3' HD13 ' A' ' 56' ' ' ILE . 15.7 Cg_exo -73.33 148.87 44.18 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 123.302 2.668 . . . . 0.0 111.859 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.84 122.9 40.5 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.6 m -78.7 20.58 0.44 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 m -71.25 -52.13 20.73 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 170.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.16 99.02 9.66 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 178.26 86.27 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 129.294 3.038 . . . . 0.0 105.418 171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -90.2 90.59 8.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.9 152.57 40.28 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.498 175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.14 -5.62 15.92 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 109.551 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.99 -95.35 0.14 Allowed Glycine 0 N--CA 1.418 -2.539 0 N-CA-C 106.241 -2.744 . . . . 0.0 106.241 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.7 m -150.49 108.9 3.15 Favored Pre-proline 0 C--N 1.285 -2.225 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -72.32 119.5 6.18 Favored 'Trans proline' 0 CA--C 1.478 -2.302 0 C-N-CA 123.131 2.554 . . . . 0.0 111.789 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.48 -98.15 0.08 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.119 -1.855 . . . . 0.0 109.799 -176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 171.33 82.78 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.303 1.441 . . . . 0.0 108.694 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -106.14 163.37 12.84 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.891 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 37' ' ' TYR . 40.3 m-80 -136.84 79.82 38.37 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 119.324 -0.951 . . . . 0.0 110.719 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 95.3 Cg_exo -49.38 -44.2 35.28 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.306 3.337 . . . . 0.0 117.162 170.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 43' ' ' LEU . 28.2 m -104.69 166.44 3.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -166.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 75.7 m -117.63 142.2 47.5 Favored 'General case' 0 C--O 1.176 -2.788 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -109.93 137.26 14.13 Favored Glycine 0 C--N 1.257 -3.826 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 -175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.589 ' HB2' ' CD ' ' A' ' 55' ' ' LYS . 50.2 m -74.31 -26.64 60.29 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.128 0.49 . . . . 0.0 109.885 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.69 26.52 1.49 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 121.884 0.85 . . . . 0.0 110.731 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 25.6 mmt 56.7 76.54 0.3 Allowed 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 126.053 1.741 . . . . 0.0 115.283 171.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB2' ' CE2' ' A' ' 37' ' ' TYR . 47.8 m -163.45 136.34 5.42 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.4 m -91.21 116.51 28.88 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.607 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -151.34 -172.41 4.21 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -169.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 168.66 -161.57 0.01 OUTLIER 'General case' 0 CA--C 1.478 -1.817 0 N-CA-C 102.715 -3.069 . . . . 0.0 102.715 169.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.387 8.0 p30 70.57 169.22 0.31 Allowed 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 0.4 OUTLIER -84.47 -0.83 54.36 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.066 -1.424 . . . . 0.0 109.849 -173.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.3 m -119.94 -27.79 5.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 5.6 m -100.3 -61.37 1.38 Allowed 'General case' 0 N--CA 1.389 -3.499 0 CA-C-O 117.493 -1.242 . . . . 0.0 111.042 176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.67 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.302 81.3 mt -78.22 -60.4 2.39 Favored 'General case' 2 C--O 1.105 -6.524 0 C-N-CA 113.85 -3.14 . . . . 0.0 108.314 179.084 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.809 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.725 41.8 m -49.82 -26.95 4.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 119.195 3.035 . . . . 0.0 119.195 -172.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 30.2 mmt -71.43 -58.84 3.15 Favored 'General case' 0 C--O 1.267 2.008 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.627 ' HG2' HD11 ' A' ' 54' ' ' ILE . 25.6 tttm -52.18 -40.83 62.04 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.443 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 44' ' ' CYS . 6.2 tt -74.4 -35.01 37.98 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.226 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -169.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 44' ' ' CYS . 31.3 mmt180 -65.48 -40.08 92.71 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 173.21 21.36 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.002 0 O-C-N 124.551 1.157 . . . . 0.0 110.651 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.36 -27.62 69.44 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.11 -71.25 0.12 Allowed Glycine 0 N--CA 1.403 -3.529 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.467 169.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -154.51 -172.78 4.32 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 102.588 -3.116 . . . . 0.0 102.588 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.53 87.98 7.46 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.67 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -43.78 132.74 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' HB2' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.12 111.89 19.46 Favored 'General case' 1 N--CA 1.378 -4.046 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 172.209 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.7 pt -72.3 139.96 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.359 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.765 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 15.1 tt -80.07 -34.14 14.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 CA-C-O 122.447 1.117 . . . . 0.0 109.229 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 30' ' ' CYS . 0.1 OUTLIER -130.77 129.26 42.23 Favored 'General case' 1 N--CA 1.367 -4.618 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.292 173.749 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.782 ' HA ' HD12 ' A' ' 56' ' ' ILE . 4.1 p-10 -77.25 4.74 9.86 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' HA3' ' HD2' ' A' ' 61' ' ' PRO . . . -170.29 -154.34 9.37 Favored Glycine 0 N--CA 1.405 -3.406 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 9.3 Cg_endo -51.4 115.29 1.98 Allowed 'Trans proline' 0 C--O 1.239 0.575 0 C-N-CA 123.921 3.081 . . . . 0.0 114.297 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 170.665 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.446 -1.267 0 N-CA-C 108.068 -1.551 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -116.89 -75.51 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 53.8 34.8 19.99 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.133 0.973 . . . . 0.0 112.124 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.15 79.25 0.64 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.482 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.7 mp -104.21 142.25 34.84 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 123.157 0.583 . . . . 0.0 111.475 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -117.26 -74.27 0.61 Allowed 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m -134.69 13.83 3.7 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.56 -176.8 3.3 Favored 'General case' 0 C--O 1.254 1.328 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -153.12 0.07 Allowed 'General case' 0 CA--C 1.565 1.556 0 O-C-N 123.936 0.773 . . . . 0.0 110.628 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.8 ptm180 -115.42 113.97 24.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.5 p -102.29 138.7 19.78 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.725 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 54' ' ' ILE . 82.0 Cg_endo -75.58 158.75 39.78 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.285 1.99 . . . . 0.0 110.398 176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.71 131.88 53.33 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.3 t -77.79 80.7 4.24 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 t -158.15 27.26 0.25 Allowed 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -131.14 28.81 4.72 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 122.472 1.13 . . . . 0.0 109.603 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 32.1 m-85 -120.82 174.69 6.45 Favored 'General case' 0 C--N 1.261 -3.277 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.746 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' H ' ' A' ' 19' ' ' LEU . 16.1 tpt180 -158.35 171.05 20.88 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 11.0 mp 85.37 140.14 0.05 OUTLIER Pre-proline 0 CA--C 1.498 -1.043 0 C-N-CA 125.56 1.544 . . . . 0.0 111.888 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.54 -22.57 51.14 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.198 1.932 . . . . 0.0 110.266 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.7 -129.62 6.73 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.712 ' SG ' ' HG3' ' A' ' 40' ' ' GLU . 94.1 m -138.9 121.45 10.52 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -79.5 117.37 3.71 Favored 'Trans proline' 0 N--CA 1.431 -2.177 0 C-N-CA 121.516 1.478 . . . . 0.0 111.138 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 4.1 mpt_? 62.9 173.17 0.15 Allowed 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 113.402 -1.727 . . . . 0.0 112.301 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -121.73 27.94 7.91 Favored 'General case' 0 C--N 1.257 -3.451 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.811 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.69 152.41 42.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.203 176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -119.19 79.86 19.42 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.224 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.884 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 51.9 Cg_exo -58.43 -46.95 21.38 Favored 'Trans proline' 0 C--O 1.204 -1.225 0 C-N-CA 122.592 2.195 . . . . 0.0 115.566 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 38' ' ' ALA . 31.7 m -105.13 171.54 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -169.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.0 m -112.08 133.91 53.94 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.913 -172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -77.73 110.21 2.98 Favored Glycine 0 C--N 1.259 -3.714 0 C-N-CA 125.092 1.33 . . . . 0.0 114.985 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 45.3 t -69.84 -35.63 74.91 Favored 'General case' 0 C--N 1.374 1.647 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.84 23.96 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.951 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.444 ' H ' ' C ' ' A' ' 32' ' ' SER . 12.7 tpt 71.56 79.94 0.16 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.603 1.961 . . . . 0.0 110.653 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -165.03 174.44 10.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 122.05 0.928 . . . . 0.0 110.692 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -138.55 110.73 7.35 Favored 'General case' 0 C--N 1.264 -3.135 0 C-N-CA 127.083 2.153 . . . . 0.0 106.829 173.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.521 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.59 -172.59 4.28 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -172.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.884 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 149.18 94.46 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 128.069 2.547 . . . . 0.0 110.269 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.47 ' HA ' ' CE1' ' A' ' 17' ' ' TYR . 10.0 p30 178.24 176.21 0.49 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 124.47 1.108 . . . . 0.0 108.504 172.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.712 ' HG3' ' SG ' ' A' ' 22' ' ' CYS . 2.9 pt-20 -83.3 6.01 21.21 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.068 -1.053 . . . . 0.0 113.301 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 90.2 m -108.79 -31.94 7.51 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 176.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 42.2 p -89.95 -67.55 0.84 Allowed 'General case' 0 N--CA 1.398 -3.031 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.06 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.28 93.2 mt -82.54 -55.18 4.63 Favored 'General case' 2 C--O 1.086 -7.515 0 C-N-CA 114.787 -2.765 . . . . 0.0 110.749 -176.105 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.72 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.301 7.6 t -55.05 -29.4 57.39 Favored 'General case' 0 C--N 1.268 -2.939 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 23.9 mmt -62.8 -62.12 1.95 Allowed 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 168.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -49.82 -46.71 51.38 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 113.27 -1.787 . . . . 0.0 113.04 176.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.259 4.5 tt -74.39 -32.07 29.92 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.406 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -165.762 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -68.85 -41.54 78.33 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 174.38 19.94 0.0 OUTLIER 'General case' 0 C--O 1.246 0.917 0 O-C-N 124.211 0.945 . . . . 0.0 110.711 173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -71.92 -24.88 75.96 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -131.58 -76.11 0.13 Allowed Glycine 0 N--CA 1.4 -3.721 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.245 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -155.63 -171.51 3.8 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -171.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.86 7.54 Favored 'General case' 0 C--N 1.273 -2.749 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 165.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.3 mp -45.37 132.79 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.719 -175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -110.88 118.62 36.61 Favored 'General case' 0 N--CA 1.384 -3.732 0 N-CA-C 101.449 -3.537 . . . . 0.0 101.449 173.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 59' ' ' ASN . 6.4 pt -74.4 134.12 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.763 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 11.3 tt -69.95 -36.83 70.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 122.616 1.198 . . . . 0.0 108.754 -175.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.54 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.274 20.2 mmm180 -131.92 142.86 49.78 Favored 'General case' 1 N--CA 1.376 -4.144 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.278 173.986 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.636 ' HA ' HD12 ' A' ' 56' ' ' ILE . 21.8 p-10 -84.38 -0.59 53.25 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.971 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.22 -128.85 0.99 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.03 29.89 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.518 2.812 . . . . 0.0 115.181 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 99.1 m . . . . . 0 C--O 1.244 0.816 0 C-N-CA 124.543 1.137 . . . . 0.0 112.395 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -1.106 0 N-CA-C 107.347 -1.828 . . . . 0.0 107.347 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 65.86 106.78 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.145 1.528 . . . . 0.0 110.897 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 65.78 -172.66 0.18 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.4 46.6 2.25 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.628 1.104 . . . . 0.0 112.801 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tt -94.02 115.43 27.76 Favored 'General case' 0 N--CA 1.401 -2.904 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -89.08 -22.19 23.04 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.12 -171.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.4 m -77.36 164.89 25.1 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.057 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.18 168.32 14.32 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.086 0.47 . . . . 0.0 112.16 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 72.76 -166.16 0.12 Allowed 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.993 1.717 . . . . 0.0 112.342 175.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.644 HH12 HD11 ' A' ' 56' ' ' ILE . 4.6 ppt_? -140.83 163.2 33.57 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.7 t -129.74 147.65 66.25 Favored Pre-proline 0 C--N 1.266 -3.029 0 O-C-N 123.445 0.466 . . . . 0.0 110.893 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.18 121.98 3.2 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.512 2.142 . . . . 0.0 110.661 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.13 114.39 11.25 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.547 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.535 ' HB2' ' OE1' ' A' ' 40' ' ' GLU . 29.0 p -94.27 -24.16 17.56 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.658 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.1 m -71.81 35.97 0.06 Allowed 'General case' 0 CA--C 1.56 1.335 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -162.54 33.11 0.11 Allowed 'General case' 0 C--O 1.244 0.784 0 CA-C-O 122.68 1.228 . . . . 0.0 109.682 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' HB3' HD13 ' A' ' 19' ' ' LEU . 4.6 m-30 -95.52 123.55 39.12 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.69 -1.595 . . . . 0.0 112.983 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -93.69 55.22 2.14 Favored 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 HD13 ' HB3' ' A' ' 17' ' ' TYR . 11.1 mp -102.32 151.77 38.2 Favored Pre-proline 0 CA--C 1.495 -1.168 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.56 -3.85 14.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.379 2.053 . . . . 0.0 109.848 172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.43 -89.51 0.13 Allowed Glycine 0 N--CA 1.414 -2.809 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 40' ' ' GLU . 81.8 m -156.94 111.09 1.95 Allowed Pre-proline 0 C--N 1.291 -1.96 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.37 118.26 5.12 Favored 'Trans proline' 0 CA--C 1.49 -1.685 0 C-N-CA 122.449 2.099 . . . . 0.0 111.499 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 5.1 mpt_? 42.96 -91.3 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.259 0 O-C-N 125.715 1.884 . . . . 0.0 111.941 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 171.56 125.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.677 1.591 . . . . 0.0 108.442 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.38 166.01 32.33 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 124.117 0.967 . . . . 0.0 108.699 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -127.11 79.21 73.37 Favored Pre-proline 0 CA--C 1.566 1.594 0 CA-C-N 118.296 0.498 . . . . 0.0 110.923 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.718 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 36.8 Cg_exo -61.36 -48.68 9.13 Favored 'Trans proline' 0 C--O 1.206 -1.118 0 C-N-CA 123.654 2.903 . . . . 0.0 116.467 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 38' ' ' ALA . 17.1 m -104.9 171.71 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB3' ' H ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -115.88 127.73 55.24 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.33 -166.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -68.23 112.01 4.4 Favored Glycine 0 C--N 1.266 -3.335 0 N-CA-C 117.234 1.653 . . . . 0.0 117.234 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.9 t -78.47 -17.2 56.65 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -87.3 16.49 5.23 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.726 1.61 . . . . 0.0 109.72 175.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 60.7 tpp 71.66 16.25 5.8 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.256 1.026 . . . . 0.0 112.039 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.6 m -125.16 112.64 16.69 Favored 'General case' 0 C--O 1.169 -3.157 0 O-C-N 121.017 -1.052 . . . . 0.0 111.446 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.5 p -72.94 121.96 20.91 Favored 'General case' 0 C--N 1.279 -2.493 0 O-C-N 121.093 -1.005 . . . . 0.0 108.755 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.559 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -153.74 -170.28 3.53 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.718 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 177.08 -159.02 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 162.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.317 7.7 p30 66.01 171.63 0.23 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 171.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 14' ' ' CYS . 8.5 mm-40 -77.1 -18.11 58.2 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.397 -176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.0 m -101.87 -27.02 13.23 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -171.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.1 m -101.23 -55.63 2.5 Favored 'General case' 1 N--CA 1.374 -4.242 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.515 176.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.881 HD22 HG21 ' A' ' 54' ' ' ILE 0.293 78.9 mt -81.55 -51.96 7.72 Favored 'General case' 2 C--O 1.108 -6.37 0 C-N-CA 114.132 -3.027 . . . . 0.0 110.654 177.869 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.725 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.292 11.1 t -58.62 -28.51 65.69 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.692 -1.203 . . . . 0.0 114.045 -169.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 89.9 mmm -70.62 -53.9 14.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 44.8 mmtt -49.13 -48.26 44.85 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.101 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.2 OUTLIER -73.1 -35.38 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.793 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.732 -162.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 48' ' ' ARG . 2.6 mmp_? -68.02 -39.36 83.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.599 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 173.54 20.32 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.76 1.287 . . . . 0.0 111.131 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.47 -29.56 63.69 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -130.71 -67.37 0.1 Allowed Glycine 0 N--CA 1.409 -3.111 0 C-N-CA 118.254 -1.926 . . . . 0.0 111.867 170.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -155.79 -172.78 4.26 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 -171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' O ' ' HE3' ' A' ' 55' ' ' LYS . 12.3 m120 -83.84 88.94 7.12 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 164.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.881 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -45.95 129.54 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.157 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.519 ' HE3' ' O ' ' A' ' 53' ' ' ASN . 27.0 mmtp -114.6 119.02 35.36 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 59' ' ' ASN . 11.2 pt -77.28 134.96 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.42 0 C-N-CA 116.618 -2.033 . . . . 0.0 106.387 174.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.0 tt -77.49 -32.19 18.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-O 123.279 1.514 . . . . 0.0 109.538 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' HA ' ' HD2' ' A' ' 58' ' ' ARG 0.408 17.9 mmm180 -128.64 129.96 46.59 Favored 'General case' 2 N--CA 1.366 -4.637 0 CA-C-N 112.588 -2.096 . . . . 0.0 111.477 171.445 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.665 ' HA ' HD12 ' A' ' 56' ' ' ILE . 39.0 p30 -82.92 21.28 1.06 Allowed 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.147 -173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.55 -160.23 24.87 Favored Glycine 0 N--CA 1.41 -3.058 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.76 139.15 32.43 Favored 'Trans proline' 0 C--O 1.251 1.17 0 C-N-CA 124.345 3.363 . . . . 0.0 116.823 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 90.6 m . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.104 172.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.447 -1.262 0 N-CA-C 109.127 -1.144 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 7.0 tt0 -91.0 162.92 14.51 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -116.35 -5.29 11.79 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.774 0.797 . . . . 0.0 110.521 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.51 ' H ' ' HG2' ' A' ' 2' ' ' GLN . . . -90.66 -70.18 1.21 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 175.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 ' O ' ' HB3' ' A' ' 2' ' ' GLN . 10.9 mp -97.99 140.57 32.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 172.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -110.02 146.09 35.91 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.694 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t 69.0 18.47 8.4 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.622 1.169 . . . . 0.0 110.323 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -149.0 138.51 21.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -86.31 -178.6 6.51 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB3' HH11 ' A' ' 10' ' ' ARG . 0.0 OUTLIER -79.84 106.05 11.58 Favored 'General case' 0 N--CA 1.413 -2.276 0 C-N-CA 123.968 0.907 . . . . 0.0 110.453 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -111.32 132.98 21.51 Favored Pre-proline 0 C--N 1.267 -2.982 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HG2' HD13 ' A' ' 43' ' ' LEU . 77.9 Cg_exo -50.4 141.65 31.95 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 124.346 3.364 . . . . 0.0 112.989 176.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -93.82 2.28 56.24 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -173.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.8 p -65.71 -41.86 91.8 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.032 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.4 p 53.19 -79.46 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.933 1.693 . . . . 0.0 113.699 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 34.8 tt0 -100.91 102.44 13.48 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 117.121 -1.418 . . . . 0.0 108.132 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.34 12.7 m-85 -160.99 75.08 0.51 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 125.478 1.736 . . . . 0.0 112.402 167.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -94.52 98.17 10.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 10.3 mp -94.46 139.92 22.53 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.946 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -81.96 -3.33 11.66 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.864 1.71 . . . . 0.0 110.014 172.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -150.56 84.83 0.16 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 19' ' ' LEU . 36.8 m -96.75 162.67 22.38 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -49.61 159.54 1.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.298 2.665 . . . . 0.0 110.756 162.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 7.9 mpt_? -79.68 -107.77 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -144.61 113.56 6.84 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.51 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 6.3 p90 -146.21 19.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 37' ' ' TYR . 3.0 m-20 -22.66 82.61 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.734 0 C-N-CA 130.161 3.384 . . . . 0.0 116.068 -167.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 80.0 Cg_exo -52.88 -47.06 29.5 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 123.934 3.089 . . . . 0.0 117.775 170.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 43' ' ' LEU . 16.4 m -104.04 169.81 2.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -160.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 60.0 m -109.06 135.82 49.58 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.087 -172.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.712 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -75.25 115.68 4.71 Favored Glycine 0 C--N 1.265 -3.361 0 CA-C-N 114.525 -1.216 . . . . 0.0 115.293 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.496 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 30.6 t -85.2 -10.32 56.77 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.24 12.77 15.06 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 48.6 ttp 87.09 19.72 0.07 Allowed 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 126.164 1.786 . . . . 0.0 112.138 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -106.47 -173.54 2.32 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 121.457 -0.777 . . . . 0.0 112.641 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.1 m -137.96 110.95 7.75 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 127.481 2.313 . . . . 0.0 105.978 172.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.712 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -152.68 -171.75 4.03 Favored 'General case' 0 C--O 1.202 -1.431 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 -168.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.771 ' O ' ' HB ' ' A' ' 42' ' ' THR . . . 173.67 -150.28 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 101.053 -3.684 . . . . 0.0 101.053 166.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 82.62 144.94 0.07 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 118.863 0.756 . . . . 0.0 111.987 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 4.5 mm-40 -79.02 -3.42 45.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 122.146 0.974 . . . . 0.0 108.542 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.518 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 1.8 m -121.38 -3.63 9.41 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.276 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.771 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 25.8 m -114.73 -60.83 1.83 Allowed 'General case' 0 N--CA 1.4 -2.96 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 171.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.29 58.9 mt -80.74 -54.64 5.45 Favored 'General case' 2 C--O 1.106 -6.484 0 C-N-CA 114.202 -2.999 . . . . 0.0 109.529 177.025 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.8 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.472 0.0 OUTLIER -56.06 -22.8 29.74 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -171.734 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.518 ' HG2' ' HA ' ' A' ' 41' ' ' CYS . 24.3 mmt -70.38 -58.96 3.17 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 168.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 15.0 tptt -50.38 -47.31 56.3 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.858 -1.519 . . . . 0.0 112.107 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.8 HG22 ' HA ' ' A' ' 44' ' ' CYS . 7.5 tt -73.98 -32.84 34.61 Favored 'Isoleucine or valine' 1 N--CA 1.373 -4.309 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.148 -167.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.415 ' HD3' ' HA ' ' A' ' 16' ' ' GLN . 26.5 tpt180 -68.06 -40.03 82.88 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.444 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 172.76 17.51 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.556 1.16 . . . . 0.0 110.927 178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.2 -25.91 67.52 Favored Glycine 0 N--CA 1.428 -1.849 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.05 -69.88 0.08 OUTLIER Glycine 0 N--CA 1.407 -3.246 0 C-N-CA 118.567 -1.778 . . . . 0.0 112.354 170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -157.48 -174.04 4.69 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 -167.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -78.57 90.57 4.53 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 162.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -51.73 137.02 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.79 136.95 54.94 Favored 'General case' 1 N--CA 1.377 -4.107 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 170.145 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.6 pt -88.77 141.45 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.242 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -76.33 -35.25 26.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 122.903 1.335 . . . . 0.0 109.455 -176.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.517 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.314 17.5 mmm180 -130.38 136.93 49.59 Favored 'General case' 1 N--CA 1.364 -4.744 0 CA-C-N 113.045 -1.889 . . . . 0.0 111.461 176.051 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.653 ' HA ' HD12 ' A' ' 56' ' ' ILE . 5.9 m120 -91.3 75.16 6.11 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.519 -172.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 29' ' ' VAL . . . 103.37 -123.01 7.66 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.85 124.56 15.62 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.476 2.117 . . . . 0.0 111.046 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.253 1.24 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo . . . . . 0 N--CA 1.437 -1.842 0 N-CA-C 107.757 -1.67 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.44 136.32 2.63 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 123.585 0.553 . . . . 0.0 111.741 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -159.06 132.12 7.09 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 125.29 1.436 . . . . 0.0 108.989 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.66 60.49 0.61 Allowed Glycine 0 C--N 1.291 -1.951 0 N-CA-C 108.941 -1.663 . . . . 0.0 108.941 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 tp -87.77 -29.82 20.74 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.345 0.593 . . . . 0.0 110.261 -176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.21 174.73 5.89 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -84.37 56.1 3.65 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.817 1.294 . . . . 0.0 110.221 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -152.77 147.08 25.65 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.92 -160.49 1.08 Allowed 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.514 HH11 ' HG3' ' A' ' 10' ' ' ARG . 1.5 ptm180 -92.82 103.67 15.99 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 122.24 1.019 . . . . 0.0 109.17 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -85.69 136.63 36.73 Favored Pre-proline 0 C--N 1.266 -3.029 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.727 178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 56' ' ' ILE . 88.1 Cg_endo -77.27 140.28 19.47 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.443 2.095 . . . . 0.0 112.184 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.85 113.5 25.05 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 24.2 p -79.36 20.06 0.56 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -85.64 3.24 41.77 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.599 0.714 . . . . 0.0 110.387 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -93.77 27.92 2.55 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.286 1.041 . . . . 0.0 110.319 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -132.35 128.43 37.66 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.773 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 4.0 tpm_? -104.67 -27.27 11.92 Favored 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.652 -177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.26 135.39 91.25 Favored Pre-proline 0 C--N 1.313 -0.987 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.532 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.4 -10.97 24.44 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.262 1.974 . . . . 0.0 110.012 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -122.62 -151.07 8.27 Favored Glycine 0 N--CA 1.412 -2.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.1 m -153.08 113.18 2.69 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -95.01 159.67 1.71 Allowed 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 123.077 2.518 . . . . 0.0 110.684 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 60.29 -170.48 0.14 Allowed 'General case' 0 N--CA 1.423 -1.79 0 CA-C-O 122.566 1.174 . . . . 0.0 111.02 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.44 102.18 5.05 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 113.635 -1.621 . . . . 0.0 107.555 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -142.61 135.86 28.59 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -128.88 80.08 73.38 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.159 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 83.6 Cg_exo -50.62 -46.36 30.19 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.246 3.298 . . . . 0.0 117.259 172.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 43' ' ' LEU . 25.3 m -103.92 161.3 4.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -165.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.5 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 95.4 m -104.76 126.32 51.72 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.156 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -68.16 117.4 8.46 Favored Glycine 0 C--N 1.27 -3.106 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.433 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 43.5 m -73.15 -33.93 65.77 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -85.01 33.94 0.54 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.179 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 90.8 mmm 67.72 17.14 9.82 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.434 1.494 . . . . 0.0 114.922 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.535 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.5 m -130.46 112.32 13.12 Favored 'General case' 0 C--O 1.163 -3.475 0 O-C-N 121.363 -0.835 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.9 m -73.76 121.22 20.47 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.11 -170.74 3.74 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 124.859 1.264 . . . . 0.0 112.771 -166.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.637 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 178.3 -159.21 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.368 7.9 p30 67.95 172.2 0.28 Allowed 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 172.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 44' ' ' CYS . 20.0 tt0 -84.27 -12.86 53.98 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.45 0.643 . . . . 0.0 110.212 -174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 59.8 m -102.59 -27.9 12.47 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -173.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 38' ' ' ALA . 4.5 m -96.42 -61.46 1.42 Allowed 'General case' 1 N--CA 1.378 -4.04 0 CA-C-O 117.417 -1.278 . . . . 0.0 109.731 174.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.769 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.297 76.2 mt -81.61 -54.05 5.73 Favored 'General case' 2 C--O 1.098 -6.906 0 C-N-CA 113.201 -3.4 . . . . 0.0 110.946 -178.434 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.746 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.258 8.9 t -55.36 -30.53 60.49 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -169.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 97.3 mmm -66.75 -58.16 5.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 171.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.17 -44.04 42.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.866 176.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG22 ' HA ' ' A' ' 44' ' ' CYS 0.269 0.1 OUTLIER -73.54 -36.18 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.991 0 C-N-CA 119.874 -0.73 . . . . 0.0 112.363 -164.198 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -68.02 -39.24 83.17 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.076 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 171.47 19.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.85 1.344 . . . . 0.0 110.64 172.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 46' ' ' LYS . . . -72.6 -23.12 78.46 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.07 -89.84 1.01 Allowed Glycine 0 N--CA 1.397 -3.934 0 C-N-CA 118.617 -1.754 . . . . 0.0 111.777 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.468 ' H ' ' CD1' ' A' ' 54' ' ' ILE . 93.0 m-70 -156.7 70.66 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.954 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 2.5 t-20 24.48 68.48 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 124.637 1.211 . . . . 0.0 111.341 -172.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 43' ' ' LEU 0.253 1.4 mp -45.74 135.02 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 117.328 2.344 . . . . 0.0 117.328 -168.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.1 OUTLIER -121.82 123.17 41.15 Favored 'General case' 0 N--CA 1.392 -3.353 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 171.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 59' ' ' ASN . 12.2 pt -80.84 135.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.045 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 175.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.433 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.1 tt -69.63 -39.89 78.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 122.354 1.073 . . . . 0.0 108.556 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.825 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.342 21.6 mmm180 -131.57 147.7 52.55 Favored 'General case' 0 N--CA 1.389 -3.5 0 CA-C-N 112.789 -2.005 . . . . 0.0 112.162 172.191 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 56' ' ' ILE . 3.4 p-10 -83.72 4.03 30.57 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.157 -1.838 . . . . 0.0 111.681 -171.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 161.46 -76.37 0.18 Allowed Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.788 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.22 121.72 6.26 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 121.954 1.769 . . . . 0.0 112.32 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 47.8 m . . . . . 0 C--N 1.303 -1.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.621 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 8.5 Cg_exo . . . . . 0 N--CA 1.449 -1.133 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -84.89 174.39 9.85 Favored 'General case' 0 C--O 1.238 0.447 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.819 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 71.52 28.2 2.89 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.228 1.411 . . . . 0.0 108.944 -173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.61 -161.4 17.04 Favored Glycine 0 N--CA 1.415 -2.762 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 45.7 tp -99.09 108.6 21.28 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 1' ' ' PRO . 29.6 p90 -109.07 112.67 24.98 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.496 0.665 . . . . 0.0 110.714 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -78.24 -12.36 59.99 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.632 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 0.1 OUTLIER -145.57 153.55 41.2 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -87.91 -160.58 0.63 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' NH1' HD11 ' A' ' 56' ' ' ILE . 3.5 ptm180 -114.17 132.82 55.95 Favored 'General case' 0 N--CA 1.383 -3.785 0 C-N-CA 118.488 -1.285 . . . . 0.0 109.828 -177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -120.68 142.84 35.07 Favored Pre-proline 1 C--N 1.244 -4.017 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.485 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.07 175.48 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.654 2.236 . . . . 0.0 113.077 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -105.31 136.49 44.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 t -92.09 -4.27 54.59 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.6 m -74.29 78.15 1.83 Allowed 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.451 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 177.72 -171.88 0.11 Allowed 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 127.733 2.413 . . . . 0.0 104.829 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 70.33 93.19 0.08 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.302 1.041 . . . . 0.0 112.415 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 5.1 mmp_? -98.52 -5.34 32.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.019 -0.672 . . . . 0.0 112.138 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.4 pt? -71.72 164.6 56.83 Favored Pre-proline 0 C--O 1.247 0.966 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -45.89 -38.32 18.02 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.574 2.183 . . . . 0.0 110.528 175.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 40' ' ' GLU . . . 116.0 34.23 1.4 Allowed Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 120.18 -1.01 . . . . 0.0 114.833 169.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.12 154.56 74.19 Favored Pre-proline 0 C--N 1.268 -2.965 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -85.97 158.3 10.14 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 121.669 1.579 . . . . 0.0 114.858 -170.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -105.19 -47.96 3.84 Favored 'General case' 0 N--CA 1.381 -3.886 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 172.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -168.78 76.82 0.11 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.028 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -172.49 150.69 2.31 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -158.55 79.5 3.05 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 92.8 Cg_exo -45.97 -45.32 17.67 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.955 3.77 . . . . 0.0 117.367 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.672 HG21 HD11 ' A' ' 43' ' ' LEU . 33.3 m -104.06 162.38 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-O 122.368 1.08 . . . . 0.0 113.38 -166.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 31.4 m -112.87 126.93 55.99 Favored 'General case' 0 N--CA 1.399 -2.978 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.088 -166.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . -65.63 122.75 23.35 Favored Glycine 0 C--N 1.27 -3.102 0 N-CA-C 116.73 1.452 . . . . 0.0 116.73 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.428 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 41.2 p -62.26 -40.46 96.27 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 170.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.07 40.41 1.0 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.534 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 15.4 tpt 69.7 0.78 3.13 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.89 1.676 . . . . 0.0 114.461 172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 15.3 m -101.86 104.07 14.79 Favored 'General case' 0 C--O 1.156 -3.861 0 O-C-N 120.841 -1.162 . . . . 0.0 111.847 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.4 m -73.09 119.72 17.73 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-O 121.784 0.802 . . . . 0.0 108.842 173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' CE1' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -151.1 -170.8 3.76 Favored 'General case' 0 C--O 1.197 -1.684 0 C-N-CA 125.764 1.626 . . . . 0.0 111.705 -166.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.591 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 174.2 -22.73 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 166.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -67.31 174.15 3.47 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.484 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 3.6 tm-20 -77.54 -8.11 57.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.19 -16.46 10.97 Favored 'General case' 0 CA--C 1.493 -1.215 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.595 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 1.6 m -96.04 -62.74 1.23 Allowed 'General case' 0 N--CA 1.392 -3.326 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.672 HD11 HG21 ' A' ' 29' ' ' VAL 0.3 79.1 mt -80.68 -60.11 2.43 Favored 'General case' 2 C--O 1.08 -7.849 0 C-N-CA 114.711 -2.796 . . . . 0.0 109.444 174.281 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.801 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.281 62.4 m -52.08 -29.33 21.05 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -168.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 43.6 tpp -69.02 -58.51 4.0 Favored 'General case' 0 C--O 1.278 2.569 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 170.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 42' ' ' THR . 0.0 OUTLIER -49.97 -45.11 51.17 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.223 173.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.801 HG22 ' HA ' ' A' ' 44' ' ' CYS . 4.5 tt -74.37 -29.94 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.379 -3.992 0 CA-C-O 121.266 0.555 . . . . 0.0 112.15 -168.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -87.45 13.76 9.41 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.336 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 116.92 23.05 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 127.154 2.182 . . . . 0.0 112.32 164.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.91 -29.71 64.61 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.74 -76.75 0.33 Allowed Glycine 0 N--CA 1.419 -2.486 0 C-N-CA 119.489 -1.339 . . . . 0.0 110.61 172.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -153.94 -171.91 4.04 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 102.24 -3.244 . . . . 0.0 102.24 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -82.67 88.96 6.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.656 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.4 mp -45.4 129.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -112.66 117.1 31.33 Favored 'General case' 1 N--CA 1.373 -4.325 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 168.499 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 59' ' ' ASN . 16.2 pt -75.8 136.33 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.627 0 C-N-CA 117.713 -1.595 . . . . 0.0 106.918 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 32' ' ' SER . 13.2 tt -71.1 -40.81 75.85 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.417 0 CA-C-O 122.743 1.258 . . . . 0.0 108.471 -177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.565 ' H ' ' HB2' ' A' ' 30' ' ' CYS 0.338 19.3 mmm180 -131.39 148.58 52.67 Favored 'General case' 0 N--CA 1.393 -3.312 0 CA-C-N 112.817 -1.992 . . . . 0.0 111.435 176.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 56' ' ' ILE . 23.8 p-10 -101.06 16.28 25.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 113.758 -1.565 . . . . 0.0 112.702 -167.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.87 -56.22 0.41 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.462 -1.352 . . . . 0.0 113.681 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -71.89 89.93 0.75 Allowed 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 122.03 1.82 . . . . 0.0 113.747 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 62.1 m . . . . . 0 C--N 1.302 -1.498 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.087 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo . . . . . 0 N--CA 1.45 -1.079 0 N-CA-C 109.054 -1.172 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -70.92 123.84 22.95 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 123.379 0.424 . . . . 0.0 110.427 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -130.66 -50.8 1.06 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.834 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.96 43.49 0.57 Allowed Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.206 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 5' ' ' LEU . 2.4 pt? -94.75 -62.34 1.34 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.111 0.482 . . . . 0.0 110.255 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 62.7 m-85 -143.12 -46.46 0.3 Allowed 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 102.248 -3.242 . . . . 0.0 102.248 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HA ' HG21 ' A' ' 11' ' ' THR . 8.4 m -75.15 97.52 3.5 Favored 'General case' 0 N--CA 1.401 -2.878 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 164.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.32 162.85 31.41 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.1 t80 63.59 -155.21 0.32 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -94.04 101.49 13.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.059 179.105 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 7' ' ' SER . 20.7 p -94.63 136.23 23.3 Favored Pre-proline 0 C--N 1.269 -2.9 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.697 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.33 109.75 2.97 Favored 'Trans proline' 0 N--CA 1.431 -2.186 0 C-N-CA 121.967 1.778 . . . . 0.0 110.324 177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.05 103.03 4.38 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.9 t -77.99 69.12 4.17 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 122.177 0.989 . . . . 0.0 112.235 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.3 m -130.15 9.9 5.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -109.65 23.7 14.06 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.884 1.326 . . . . 0.0 109.677 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' OH ' ' HB1' ' A' ' 38' ' ' ALA . 58.1 m-85 -134.08 99.4 4.41 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-N 112.173 -2.285 . . . . 0.0 106.992 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -112.76 21.24 15.74 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.856 -172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.2 mp -76.55 134.56 69.47 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.22 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.23 -21.56 41.69 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 122.015 1.81 . . . . 0.0 109.882 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.46 -129.52 6.7 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 40' ' ' GLU . 27.2 t -145.86 129.87 8.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 117.588 0.694 . . . . 0.0 109.879 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 26' ' ' PHE . 26.7 Cg_exo -46.41 156.81 0.52 Allowed 'Trans proline' 0 C--N 1.363 1.327 0 C-N-CA 123.933 3.089 . . . . 0.0 114.64 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.8 mmt85 -66.27 -95.9 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.438 -1.255 . . . . 0.0 113.672 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 27' ' ' ASN . 45.4 t-80 -171.73 32.25 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' O ' ' HD3' ' A' ' 28' ' ' PRO . 0.3 OUTLIER -78.9 26.23 0.25 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.535 -175.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.521 ' CG ' ' HA ' ' A' ' 37' ' ' TYR . 87.9 m-20 -22.59 83.62 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 130.01 3.324 . . . . 0.0 116.276 -167.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.761 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 59.0 Cg_exo -50.25 -48.7 18.87 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 124.079 3.186 . . . . 0.0 116.88 169.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.852 HG22 ' HB2' ' A' ' 38' ' ' ALA . 30.4 m -104.66 172.39 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 -163.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 70.8 m -113.79 133.3 55.47 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.984 -172.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -76.07 116.6 4.83 Favored Glycine 0 C--N 1.256 -3.878 0 N-CA-C 118.754 2.262 . . . . 0.0 118.754 -178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 45.9 t -79.59 -20.58 46.56 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 171.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.07 10.77 9.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.473 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.7 ttm 61.99 68.38 0.69 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.841 1.657 . . . . 0.0 111.738 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.58 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 71.1 m -173.44 109.98 0.17 Allowed 'General case' 0 C--O 1.169 -3.138 0 C-N-CA 125.845 1.658 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.7 m -73.35 121.31 20.23 Favored 'General case' 0 C--N 1.255 -3.524 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.75 -172.93 4.36 Favored 'General case' 0 C--O 1.2 -1.521 0 C-N-CA 123.761 0.824 . . . . 0.0 112.488 -168.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.852 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 153.93 82.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 126.377 1.871 . . . . 0.0 109.738 164.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 HD22 ' CB ' ' A' ' 42' ' ' THR . 26.3 m-80 -154.84 166.77 32.43 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 13.7 tp10 -65.53 -21.44 66.61 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 123.94 0.775 . . . . 0.0 109.986 178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.55 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 35.2 m -120.88 -11.77 8.9 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 3.5 m -90.94 -62.32 1.48 Allowed 'General case' 0 N--CA 1.388 -3.553 0 C-N-CA 118.539 -1.264 . . . . 0.0 108.34 172.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.747 ' CD2' HG21 ' A' ' 54' ' ' ILE 0.305 29.1 mt -84.25 -53.25 5.62 Favored 'General case' 2 C--O 1.087 -7.449 0 C-N-CA 114.783 -2.767 . . . . 0.0 109.946 177.557 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.823 ' HA ' HG22 ' A' ' 47' ' ' ILE . 26.7 m -61.63 -26.79 68.22 Favored 'General case' 0 C--N 1.252 -3.666 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -167.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 12.0 tpt -70.33 -54.82 10.97 Favored 'General case' 0 N--CA 1.42 -1.969 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.623 ' HB2' ' O ' ' A' ' 42' ' ' THR . 8.8 tptp -52.13 -43.89 64.24 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 124.514 1.126 . . . . 0.0 111.034 176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 44' ' ' CYS . 9.4 tt -74.02 -33.41 35.97 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.496 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 71.4 ttt180 -72.1 -42.35 66.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -174.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 45.2 mt-10 -178.55 17.07 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.682 1.593 . . . . 0.0 108.465 173.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -72.26 -29.1 66.87 Favored Glycine 0 CA--C 1.482 -1.972 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.34 -65.58 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.546 0 C-N-CA 118.674 -1.727 . . . . 0.0 111.452 168.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -156.52 -172.2 3.98 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 104.204 -2.517 . . . . 0.0 104.204 -167.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -90.62 86.83 6.5 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.747 HG21 ' CD2' ' A' ' 43' ' ' LEU . 1.1 mp -51.5 134.16 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.48 137.25 54.94 Favored 'General case' 0 N--CA 1.388 -3.526 0 N-CA-C 103.071 -2.937 . . . . 0.0 103.071 166.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 59' ' ' ASN . 8.1 pt -84.68 147.36 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.841 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -81.94 -34.61 12.73 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-O 122.545 1.164 . . . . 0.0 108.943 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.561 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 16.5 mmm180 -134.98 140.88 46.04 Favored 'General case' 1 N--CA 1.376 -4.166 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.715 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.655 ' HA ' HD12 ' A' ' 56' ' ' ILE . 69.7 m-20 -75.47 -6.68 51.37 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.418 -1.264 . . . . 0.0 112.434 -174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 28' ' ' PRO . . . 174.24 -82.22 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.029 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -68.11 129.82 20.2 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.026 1.818 . . . . 0.0 112.962 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 23.6 m . . . . . 0 C--N 1.304 -1.374 0 C-N-CA 125.142 1.377 . . . . 0.0 107.504 177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 109.945 -0.829 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -61.64 113.1 2.52 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.285 0.634 . . . . 0.0 110.992 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.7 t80 65.05 28.29 12.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.634 1.174 . . . . 0.0 110.181 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.96 55.25 4.9 Favored Glycine 0 C--O 1.216 -1.001 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.094 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 pp -91.56 -10.07 41.93 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.045 0.45 . . . . 0.0 111.098 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 60.5 91.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.033 1.333 . . . . 0.0 113.895 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.8 m -163.15 -53.96 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.12 166.26 30.33 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 169.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' A' ' 57' ' ' ILE . 0.5 OUTLIER -99.2 -158.37 0.67 Allowed 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' NH1' HD11 ' A' ' 56' ' ' ILE . 6.6 ptm180 -105.35 136.34 45.07 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.2 t -113.61 137.05 22.04 Favored Pre-proline 0 C--N 1.251 -3.7 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.726 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.74 128.06 4.44 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.126 2.55 . . . . 0.0 110.772 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 95.27 10.18 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.7 p -78.41 6.86 7.54 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.491 0.663 . . . . 0.0 110.254 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.8 m -58.11 -37.18 74.06 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 124.932 1.293 . . . . 0.0 108.438 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -101.7 97.12 7.57 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 11.7 m-85 164.16 137.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 130.052 3.341 . . . . 0.0 106.525 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 17' ' ' TYR . 2.1 mpt_? -128.76 115.91 18.69 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.868 0.366 . . . . 0.0 111.022 176.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.1 mp -92.25 138.76 24.16 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.339 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.48 -1.93 12.1 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.059 1.839 . . . . 0.0 111.079 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.08 -111.52 0.25 Allowed Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 23' ' ' PRO . 39.8 m -131.51 166.22 29.65 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 22' ' ' CYS . 13.9 Cg_endo -81.52 151.38 17.3 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-N 120.483 1.208 . . . . 0.0 114.576 -171.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -97.45 -146.99 0.31 Allowed 'General case' 0 N--CA 1.391 -3.391 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -77.06 82.04 3.58 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -156.19 118.75 4.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.672 170.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -135.0 79.86 49.9 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.848 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 52.9 Cg_exo -56.98 -49.9 13.03 Favored 'Trans proline' 0 C--O 1.202 -1.3 0 C-N-CA 124.058 3.172 . . . . 0.0 117.696 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 38' ' ' ALA . 32.8 m -104.07 159.52 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.783 0.801 . . . . 0.0 113.027 -167.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.3 m -101.8 122.61 44.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.759 -173.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -63.32 115.38 7.92 Favored Glycine 0 C--N 1.269 -3.192 0 N-CA-C 116.304 1.282 . . . . 0.0 116.304 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.545 ' HB3' ' HG3' ' A' ' 55' ' ' LYS . 34.9 t -81.61 -26.73 34.64 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -90.73 20.03 5.02 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.571 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 51.8 ttm 68.14 82.92 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.346 1.858 . . . . 0.0 112.856 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 33.0 m 172.24 108.24 0.01 OUTLIER 'General case' 0 C--O 1.163 -3.48 0 C-N-CA 126.992 2.117 . . . . 0.0 110.328 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -73.87 120.01 18.87 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' N ' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -153.11 -171.12 3.82 Favored 'General case' 0 C--O 1.185 -2.339 0 C-N-CA 124.943 1.297 . . . . 0.0 113.496 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . . . 152.86 114.02 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 126.265 1.826 . . . . 0.0 110.25 162.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 HD21 ' HG3' ' A' ' 23' ' ' PRO . 8.8 p30 162.04 -176.88 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.903 0 O-C-N 125.254 1.597 . . . . 0.0 108.859 173.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 43.2 mt-10 -76.9 -26.44 54.14 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.418 ' HA ' ' HG3' ' A' ' 45' ' ' MET . 28.2 t -99.56 -14.05 19.18 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.293 1.045 . . . . 0.0 109.628 -170.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 9.0 m -105.81 -58.41 1.91 Allowed 'General case' 0 N--CA 1.385 -3.697 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.849 170.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 54' ' ' ILE 0.261 97.1 mt -81.41 -58.99 2.79 Favored 'General case' 2 C--O 1.093 -7.182 0 C-N-CA 114.098 -3.041 . . . . 0.0 111.914 179.94 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.714 ' HA ' HG22 ' A' ' 47' ' ' ILE 0.357 35.9 m -53.11 -26.36 16.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -172.096 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 41' ' ' CYS . 51.8 mtt -67.59 -60.9 2.18 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HA ' ' HA3' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -48.15 -47.57 34.77 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.097 174.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.714 HG22 ' HA ' ' A' ' 44' ' ' CYS . 0.3 OUTLIER -73.19 -37.09 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.505 0 C-N-CA 120.129 -0.628 . . . . 0.0 111.582 -164.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -65.99 -39.73 90.56 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 172.18 21.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 O-C-N 124.339 1.024 . . . . 0.0 110.058 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -75.34 -25.79 67.46 Favored Glycine 0 CA--C 1.474 -2.49 0 N-CA-C 107.78 -2.128 . . . . 0.0 107.78 177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -134.51 -69.97 0.07 OUTLIER Glycine 0 N--CA 1.398 -3.858 0 C-N-CA 118.412 -1.851 . . . . 0.0 111.811 170.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -157.96 -172.32 3.87 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 -168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -82.76 93.66 7.46 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 164.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 43' ' ' LEU . 1.4 mp -53.59 127.95 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 CA-C-O 122.206 1.003 . . . . 0.0 113.624 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.545 ' HG3' ' HB3' ' A' ' 32' ' ' SER . 19.6 pttm -127.22 150.92 49.32 Favored 'General case' 0 N--CA 1.385 -3.676 0 N-CA-C 103.149 -2.908 . . . . 0.0 103.149 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.61 HD12 ' HA ' ' A' ' 59' ' ' ASN . 15.9 pt -111.24 149.04 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.575 0 C-N-CA 118.478 -1.289 . . . . 0.0 111.192 -177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 14.4 tt -82.37 -35.78 13.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.101 -175.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.22 38.47 Favored 'General case' 1 N--CA 1.361 -4.875 0 CA-C-N 113.872 -1.513 . . . . 0.0 108.529 175.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.61 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.6 p30 -85.83 114.55 22.85 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.44 -167.38 28.7 Favored Glycine 0 C--N 1.262 -3.536 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -60.28 148.93 88.25 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 121.923 1.748 . . . . 0.0 110.786 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.109 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 N--CA 1.443 -1.454 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 7' ' ' SER . 65.4 tt0 -72.73 160.73 31.73 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 123.941 0.776 . . . . 0.0 109.855 -179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 56.3 t80 68.69 70.29 0.29 Allowed 'General case' 0 C--O 1.254 1.303 0 CA-C-O 122.65 1.214 . . . . 0.0 109.523 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.43 -79.62 1.81 Allowed Glycine 0 N--CA 1.425 -2.075 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.317 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 6' ' ' PHE . 2.8 pp 170.28 -22.54 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.51 1.524 . . . . 0.0 109.2 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.4 ' N ' HD12 ' A' ' 5' ' ' LEU . 48.2 p90 -84.66 6.57 23.58 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 2' ' ' GLN . 34.3 t -87.61 157.32 19.15 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -77.72 168.83 19.33 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' CE2' HG13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -70.52 173.82 6.55 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 115.619 1.711 . . . . 0.0 115.619 -175.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.519 HH12 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.93 109.65 21.09 Favored 'General case' 1 N--CA 1.364 -4.759 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.294 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.6 m -78.56 132.2 66.01 Favored Pre-proline 0 C--N 1.251 -3.677 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.59 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HG3' HD13 ' A' ' 43' ' ' LEU . 38.5 Cg_endo -65.47 141.08 66.02 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.799 2.333 . . . . 0.0 111.078 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.32 73.99 0.86 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -96.64 -5.65 38.47 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.315 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 m -78.78 -1.6 35.51 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.019 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -100.9 20.82 14.69 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 122.785 1.279 . . . . 0.0 109.244 176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 53.5 m-85 -134.88 158.99 42.81 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.738 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 17' ' ' TYR . 3.4 mpt_? -130.12 107.69 9.51 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 175.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB3' ' H ' ' A' ' 21' ' ' GLY . 10.6 mp -95.52 170.19 8.13 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.548 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.49 -27.24 84.48 Favored 'Trans proline' 0 C--N 1.353 0.789 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 163.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' H ' ' HB3' ' A' ' 19' ' ' LEU . . . 133.2 -67.69 0.56 Allowed Glycine 0 N--CA 1.403 -3.552 0 CA-C-N 113.591 -1.64 . . . . 0.0 111.609 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.2 m -103.71 160.95 24.46 Favored Pre-proline 0 C--N 1.266 -3.063 0 CA-C-N 114.313 -0.943 . . . . 0.0 111.609 -167.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 19.7 Cg_endo -89.6 160.6 5.31 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.972 2.448 . . . . 0.0 113.353 -175.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -75.05 -37.71 61.6 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 54.7 t60 175.28 -28.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.197 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -43.79 129.21 5.62 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -130.79 80.55 69.5 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.868 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 50.1 Cg_exo -55.9 -49.39 15.76 Favored 'Trans proline' 0 C--O 1.204 -1.209 0 C-N-CA 123.87 3.046 . . . . 0.0 116.95 175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 38' ' ' ALA . 27.6 m -103.01 168.91 2.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.92 0.867 . . . . 0.0 113.236 -167.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' H ' ' A' ' 58' ' ' ARG . 71.8 m -112.1 131.68 55.3 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.237 -168.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 35' ' ' SER . . . -72.98 112.14 3.8 Favored Glycine 0 C--N 1.258 -3.766 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 32.3 t -88.7 -14.82 36.36 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' OD2' ' HA ' ' A' ' 54' ' ' ILE . 9.4 m-20 -104.38 28.42 6.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.476 177.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.5 tpt 61.75 76.21 0.38 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.47 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 27.5 m 171.13 117.28 0.01 OUTLIER 'General case' 0 C--O 1.167 -3.258 0 C-N-CA 127.403 2.281 . . . . 0.0 111.071 173.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.2 t -74.11 123.05 23.7 Favored 'General case' 0 C--N 1.265 -3.081 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.497 ' CE1' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -151.9 -171.84 4.05 Favored 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.879 ' HB2' HG22 ' A' ' 29' ' ' VAL . . . 150.99 100.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 127.603 2.361 . . . . 0.0 109.414 166.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 23' ' ' PRO . 10.0 p30 168.63 -179.55 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 125.252 1.421 . . . . 0.0 108.769 173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' CYS . 28.7 tt0 -84.12 -1.04 54.23 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.294 0.569 . . . . 0.0 111.15 -171.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 71.4 m -116.62 -22.38 8.68 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 51.0 p -89.88 -61.27 1.73 Allowed 'General case' 0 N--CA 1.403 -2.78 0 C-N-CA 118.097 -1.441 . . . . 0.0 109.919 172.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.812 HD22 HG21 ' A' ' 54' ' ' ILE 0.274 68.1 mt -88.8 -53.61 4.54 Favored 'General case' 2 C--O 1.094 -7.082 0 C-N-CA 114.704 -2.798 . . . . 0.0 111.679 -179.252 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.753 ' HA ' HG22 ' A' ' 47' ' ' ILE . 1.7 m -66.6 -25.69 66.73 Favored 'General case' 0 C--N 1.247 -3.861 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.603 -167.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.557 ' HB2' ' HA ' ' A' ' 41' ' ' CYS . 16.0 tpt -67.06 -56.7 8.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 168.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 42' ' ' THR . 11.8 mptt -50.65 -45.35 57.85 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 124.069 0.947 . . . . 0.0 112.696 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 44' ' ' CYS . 8.1 tt -73.05 -36.27 50.37 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.043 -163.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -68.72 -39.04 80.62 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' GLY . 13.4 pt-20 171.68 21.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 124.193 0.933 . . . . 0.0 109.983 174.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 46' ' ' LYS . . . -73.39 -31.58 60.93 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.85 -68.22 0.08 OUTLIER Glycine 0 N--CA 1.402 -3.619 0 C-N-CA 118.021 -2.038 . . . . 0.0 113.123 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -157.9 -172.13 3.8 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.42 93.69 8.34 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 164.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG21 HD22 ' A' ' 43' ' ' LEU . 1.2 mp -57.26 132.31 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.112 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' SER . 2.6 ptpp? -125.27 121.24 33.48 Favored 'General case' 1 N--CA 1.37 -4.46 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 59' ' ' ASN . 13.9 pt -76.83 143.51 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.134 0 C-N-CA 117.451 -1.7 . . . . 0.0 107.577 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 ' CE2' ' A' ' 9' ' ' TYR . 12.8 tt -73.99 -39.5 51.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 62' ' ' CYS 0.526 22.1 mmm180 -128.66 130.28 47.0 Favored 'General case' 0 N--CA 1.401 -2.907 0 CA-C-N 113.428 -1.715 . . . . 0.0 115.358 175.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.568 ' HA ' HD12 ' A' ' 56' ' ' ILE . 9.0 p30 -90.74 76.39 6.43 Favored 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 112.685 -2.052 . . . . 0.0 109.731 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 134.95 -175.81 20.37 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.55 122.32 7.77 Favored 'Trans proline' 0 C--O 1.245 0.849 0 C-N-CA 122.691 2.26 . . . . 0.0 113.701 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 58' ' ' ARG . 74.2 m . . . . . 0 C--N 1.307 -1.241 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.24 . . . . . . . . 1 1 . 1 stop_ save_